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Abstract 
The major current hurdle to widespread deployment of zebrafish embryos and larvae in 
large-scale drug discovery is the problem of enabling analytical platforms with high 
throughput. In order to spearhead drug discovery using zebrafish as a model, platforms 
need to determine pre-test sorting of organisms to ensure quality control and 
standardisation, and determine that their in-test positioning is suitable for high-content 
imaging with modules for flexible drug delivery. Manual procedures for sorting hundreds of 
embryos are very monotonous and therefore liable to significant analytical errors caused by 
operators’ fatigue. In this thesis, we present an innovative proof-of-concept design for a 
micromechanical large-particle in-flow sorter.  
This thesis investigated infra-red sensor detection and image acquisition and compared 
them for their ability to distinguish between viable and dead embryos. High-definition 
additive manufacturing systems for fabrication of 3D printed moulds of the type used in soft 
lithography were also explored. 3D printing using SLA provides a rapid microfabrication of 
the moulds with high definition and optical transparency, as is confirmed by both scanning 
electron microscopy and confocal microscopy. SLA technologies may be applied for the 
rapid and accurate fabrication of millifluidic devices that can trap millimetre-sized 
specimens such as living zebrafish larvae. We applied this new manufacturing method in a 
proof-of-concept prototype device capable of trapping and immobilising living zebrafish 
larvae for the purpose of recording heart rate variations in cardio-toxicity experiments.  
Static conventional culture plates limit the throughput data, and is not suitable for modern 
compound library screening, while currently available conventional microtiter well plates 
require manual pipetting, which is labour intensive and time consuming. This research offers 
promising avenues for the development of a miniaturised, automated system for handling 
and manipulating zebrafish embryos and larvae, using innovative microfluidic lab-on-chip 
(LOC) technologies and additive manufacturing technologies.  
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1 Introduction 
1.1 Phenotype-based physiological analysis 
Phenotype-based analysis is the study of an organism’s biochemical, physiological, 
morphological and behavioural characteristics. It is a screening process used in drug 
discovery and biological research to evaluate phenotypic changes or alterations caused by a 
substance such as a small molecules or peptide on a cell or organism. Phenotypic screening 
has been fundamental in the finding of new drugs, particularly in traditional and modern 
pharmacology [1]; for instance, when a genetic mutation occurs through small particle 
treatment, the change to the phenotype is observed and conclusions about the mechanism 
underlying the biology are drawn. This improves understanding in the areas of basic and 
disease biology [2]. 
Two broad types of screening approach dominated the early stages of drug development: 
phenotypic and target-based. Both approaches have advantages and limitations, but the 
contributions of phenotypic screening exceed those of target-based screening [3] because 
they offer better potential to discover new chemical probes and new biological small-
molecule targets. Phenotypic assays also have an advantage over target-based screening 
because they can identify drug leads and clinical candidates that are likely to possess 
therapeutic abilities [4]. For example, the compound of drugs were screened in phenotypic 
assays to identify the active lead compounds that alleviate the disease phenotype, 
demonstrated by selectively killing the cancer cells [5] .  
However, using cell lines in phenotypic screening uses immortalised cell line assays to 
predict the clinical efficacy of phenotypically discovered drugs. Most target hits from 
traditional screening are found to be invalid once tested in an animal model such as a 
mouse model. Factors such as absorption, solubility and toxicological problems in animal 
studies may present difficulties and lead to analysis failure [6]. Cost limits the use of 
traditional animal models in large-scale screening, so small model organisms offer a 
potential alternative as screening tools in drug discovery [7]. 
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1.1.1 The role of small model organisms in phenotype-based analysis  
To overcome the drawbacks associated with standard animal models and to avoid unethical 
procedures, alternatives were recommended under the concept of the 3Rs (replacement–
reduction–refinement) of the laboratory use of animals [8]. The concept encourages the 
replacement of higher vertebrates with microorganisms, plants, eggs, amphibians and 
invertebrates [9-11] (Table 1.1). This enables less expensive animals to be used to screen 
large numbers of drugs for toxicity analysis: reduction in this context is the minimisation of 
the number of large animal models used to perform an experiment. With careful 
experimental design and a sophisticated statistical analysis it is possible to use fewer 
animals and still obtain valid results. Furthermore, experiment protocols can be refined and 
simplified to lessen pain or distress in tested animals.  
They have been used to study various diseases, memory dysfunction, Parkinson’s disease, 
cell aging, diabetes and toxicology [12-15]. These invertebrates offer advantages as they are 
small in size, have a short life cycle, and possess a simple anatomy. A high number can be 
used in one experiment in a short period of time. However, they have immature organ 
systems and do not have adaptive immune systems which limits their use in human disease 
research [7].  
Lower vertebrates such as tadpoles (Xenopus laevis) [16, 17] and fish are an attractive 
substitute due to their genetic similarity with higher vertebrates, including mammals. Small 
fish such as the fathead minnow (Pimephales promelas), Japanese medaka (Oryzias latipes), 
and zebrafish (Danio rerio) are used as surrogate models for other vertebrates, particularly 
in the study of developmental biology, genetics and environmental toxicity. Fish offer 
significant advantages over other mammalian models in biomedical research that focuses 
on human health [18-20], and can be selected for their size, short life cycle, and high 
fecundity. With such advantages, these vertebrates are cost effective and valid models for 
human diseases. 
 
 
  4 
Table 1.1 Overview of small model organism characteristics for drug screening. Red boxes indicate 
the poorest in the category (Adapted from reference [8, 11, 21]) 
Model 
features 
Invertebrates Vertebrates 
C. Elegans Drosophila Zebrafish Xenopus Chicken Mouse 
Average 
adult size 
1 mm 3 mm 4 cm 10 cm 40 cm 10 cm 
Generation 
time 
3–5 days 10–14 days 3–4 months 4–6 months 20 weeks 3–4 weeks 
Average 
embryo size 
50 µm 100 µm 1 mm 1 mm 4 cm 8 mm 
Embryo 
accessibility 
Good Good Good Good Good Poor 
Cost per 
embryo 
Low Low Low Low Medium High 
Screening 
throughput 
High High Medium Medium Low Low 
 
1.1.2 Zebrafish as a model organism in biomedicine  
The freshwater teleost zebrafish (Danio rerio) is an attractive option for biological research 
over other model species such as the common fruit fly, worms, or tadpoles. It has an 
approximate size of 1.1–1.3 mm in diameter as an embryo and 2–4 cm as an adult. Zebrafish 
have been used as experimental models in embryogenesis, organogenesis and general 
development of vertebrates [22, 23]. This species can be modified genetically, and as a 
result been used in high-throughput studies in drugs discovery models for human diseases 
such as neurogenerative disorders [24] and cancer [25]. 
The unique characteristics of the zebrafish have made it a versatile model, and one with 
remarkable similarities to mammalian development (Figure 1.1) [26]. Zebrafish are nearly 
transparent in early development, which allows in vivo visualisation of their development 
and functions. Advanced microscope technologies allow the imaging of developmental 
details of the embryos, and assessment of drug effects on internal organs can be captured 
[27]. Recently, zebrafish have become an outstanding model for studies of heart 
development and restoration [28]. The zebrafish heart resembles the human heart in many 
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ways: beat rates are reported to be identical where the electrocardiograms (ECG) patterns 
showed were comparable to ECG patterns in humans [29]. Zebrafish have already been 
reported as a powerful and versatile vertebrate system that can facilitate accelerated drug 
discovery. Unlike fruit flies and worms, their transparent embryos are produced in large 
numbers and are accessible for rapid screening and experimental manipulation. A female 
zebrafish is capable of producing hundreds of eggs at a time, providing a sample size large 
enough to be utilised for multiple testing of drugs; this means that, among other 
advantages, potential drug toxicity problems in early drug discovery pipelines can be rapidly 
identified in the in vivo pharmacological assessment  using zebrafish embryos [30].  
 
Figure 1.1 A transgenic line zebrafish contains enhanced green fluorescent protein (eGFP) under the 
control of T cell-specific kinase p56lck. In six days post fertilization (dpf) (A) and zebrafish adult (C), 
the T-cells’ fluorescent green thymus is illuminated, as shown by the arrow. (B) No fluorescence is 
displayed in the thymic area, which indicates an immunodeficiency. (C) The fluorescence has spread 
from the thymus to the gills, face and body, showing T cell malignancy. (Taken from reference [26]. 
Reprinted with permission from ©2008 Elsevier Publishing Group). 
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The rapid embryonic development of zebrafish compared to other mammalian models also 
makes it an ideal model for high-throughput screening [31]. For instance, embryos achieved 
early vertebrate movement defined as twitching at the 19 hour somite developmental 
stage. Most major organs are developed, including the gut and the vasculature, two days 
post-fertilisation (dpf), and the embryogenesis stage is completed after five dpf [22]. In 
addition, during organogenesis the embryos are permeable to small particles and drugs, 
providing easy access for drug administration [32].  
1.1.3 Zebrafish as a model organism in ecotoxicology  
There is increasing awareness and concern about the environmental effects of industrial 
waste. In this regard, zebrafish offer many advantages which make them highly attractive in 
toxicology studies. They represent an attractive model for the environmental risk 
assessment of chemical pollutants since they are able to perform on a small scale with high-
throughput analysis. They are reported to be a powerful in vivo model system for measuring 
biological interactions and mechanisms to deal with a toxic substance [33]. Given the other 
advantages of zebrafish, the effect of both short- and long-term exposure to chemical 
pollutants including carcinogenic agents can carried be studied conveniently. Toxicity tests 
may then be designed to measure specific concentrations of chemicals that induce an effect 
on the organisms. 
The study of acute toxicity on zebrafish started in the 1980s to examine the effect of 
wastewater and effluents from industrial wastage [34] but it is now incompatible with 
current animal welfare legislation because the end point is mortality and the fish suffer 
distress and pain [35, 36]. The fish embryo test (FET) is a promising substitute for the acute 
toxicity test, and can evaluate the toxicity effect at an early stage of the life cycle. The early 
life stages of zebrafish provide a useful alternative experimental model because at this stage 
the fish are more sensitive than the adults [37, 38].  
One of the first applications for zebrafish embryos in ecotoxicology was promoted by Nagel 
et al. to develop an alternative to the 96-h acute fish toxicity test [39]. It demonstrated that 
the replacement tests were comparable with the conventional acute toxicity test [40]. 
Originally, FET analysis was designed as alternative to the acute toxicity test such as OECD 
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TG 203 (Figure 1.2) [40]. Since then, the test using zebrafish embryos has been optimised, 
standardised and validated by an OECD validation study, and adopted as OECD TG236 to 
assess toxicity in embryonic forms of fish [40]. Additional lethality endpoints makes the FET 
a versatile tool for multitude toxic effects detection, including teratogenicity, neurotoxicity, 
genotoxicity and mutagenicity [36, 40]. 
 
Figure 1.2 Fish embryo test (FET) analysis procedure (left to right): egg collection; the eggs; pre-
exposure of fish media in a petri dish; collection of fertilized eggs with an inverted microscope; 
distribution of the eggs into 24 multi-well plates. (Taken from reference [40]. Reprinted with 
permission from ©2008 Elsevier Publishing Group). 
1.1.4 Phenotyping screening : state-of-the-art using zebrafish embryonic stages 
Zebrafish are known as the most suitable model organism for phenotype screening to high-
content screening (HCS). It is a well known emerging system for in vivo studies related to 
human disease and drug discovery. Zebrafish have also been used to study pathogenic 
mechanisms in different conditions including cancer and drug discovery. 
HCS assays are used for identifying potentially hazardous compounds, using transgenic 
zebrafish (TG) (fli1:egfp) that steadily express enhanced green fluorescent protein (eGFP) 
within the vascular endothelial cells [41-43]. The development of a 384-well HCS assay by 
Leet et al. has enabled screening of the chemicals affecting cardiovascular development and 
functions within individual live embryos of 5 to 72 hpf exposed to doses at non-teratogenic 
concentrations [44] (Figure 1.3). It incorporates both morphological and functional 
endpoints in a larger sample size and in a wide range of concentrations. With this, a HCS 
  8 
assay provides a robust whole-organism-based platform for preclinical toxicology that 
focuses on the rapid identification of chemicals. 
In addition, engineered pigment-free phenotype transgenic zebrafish models (TG) can be 
used to identify targeted gene expression through the expression of fluorophores [43, 45]. 
Recently, Green et al. developed a new TG with a fluorescent estrogen response element 
(ERE) reporter and silenced skin pigmentation (Casper phenotype). High sensitivity assays 
are applicable for chemical screening with image analysis for quantifying whole-body 
responses to estrogenic chemicals. This enables the visualisation of estrogen induced tissue-
specific transcriptions in an intact zebrafish in real time. It improves the ability to predict 
potentionally adverse outcomes in human and wildlife populations.  
 
Figure 1.3 Dorsal orientation of zebrafish images at each time point (30, 48 and 72 hpf) for vehicle 
(0.1% DMSO) and 0.195 µm of butafenacil exposure. O-dianisidine staining was used to assess the 
presence of haemoglobin in embryos. Haemoglobin-positive cells appeared within the vehicle 
control embryos after circulation, but were absent following exposure to 0.195 mM of butafenacil. 
At 48 and 72 hpf, embryos exposed to 0.195 mM butafenacil displayed significantly less 
haemoglobin than the vehicle controls. Scale bar is 200 µm. (Taken from reference [44]. Reprinted 
with permission from ©2014 PLOS One). 
Despite the advantages of embryonic zebrafish model system for phenotypic screening, 
procedures such as dispensing, treating and analysing zebrafish embryos are still labour-
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intensive, manual procedures. Conventional microtiter plates are still used for drug 
screening bioassays [46-48]. This manual dispensing technique is time consuming and does 
not offer the high-throughput processing capacity required by the pharmaceuticals industry. 
Alternative tools or approaches such as automation for drug screening are being developed 
to allow more rapid and more successful identification in drug candidate selection with 
high-throughput outcomes. 
1.1.5 Automation of zebrafish embryonic bioassays: promises and challenges  
In the last two decades, drug research has developed tremendously and high-throughput 
screening has become the foundation technology of pharmaceutical research. Its 
development has been influenced by advances in the automation system for handling and 
manipulation of zebrafish embryos, which is still being developed [49]. For example, the 
conventional 96-well plates have been replaced with 384-well microplates [50], and a 
fluorescence-based detection system [51] and screening robot approach have been fully 
adapted to high-throughput screening [52, 53]. However, these advancements concentrate 
on automation screening of the chemical libraries, and it is necessary that the general 
handling and manipulation of small model organisms such as zebrafish embryos must be 
performed in an automatic manner to generate comparable, homogeneous and reliable 
data. 
The Complex Object Parametric Analyzer and Sorter (COPAS) Biosort (Union Biometrica, MA, 
USA) allows the automatic dispensing of large numbers of small organisms into multiwell 
plates to avoid manual manipulation of the embryos [54]; it improves both quality and 
screening output. It can rapidly sort objects based on various criteria, including optical 
density and length. ZebraFactor has been developed for embryo sorting and dispensing 
systems which incorporate robotic manipulations (Figure 1.4) [55]. Although its speed no 
greater than that of manual dispensing, it offers a great advantages as an unsupervised and 
continuous operation that may improve high-throughput screening. Recently, advanced 
technology integrating robotic and micro-capillary fluidics was developed for full 
automation [56, 57]. This greatly simplifies in vivo specimen manipulation and cellular organ 
imaging, which can now process multiple organisms simultaneously. 
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Figure 1.4 Detail configuration of the ZebraFactor system, comprising the WellPlateFeeder (left) and 
CellSorter (right) using a tubing system as connection. Bar scale is 50 mm. (Taken from reference 
[55]. Reprinted with permission from ©2011 Society for Laboratory Automation and Screening). 
Although labour intensive manipulations have been improved by such highly advanced high-
throughput screening, the technologies still lack reliable, user friendly, affordable laboratory 
automations. Moreover, some advanced systems require expensive visual and automation 
equipment which increases the cost of operations. With the introduction of microfluidic 
technologies, innovative devices for automatic manipulation and bioanalysis of zebrafish 
offer new opportunities for high-throughput screening.  
1.2 Microfluidic lab-on-a-chip (LOC) technologies  
Microfluidics is an advance technique that enables the manipulation of small amounts of 
fluids at a range of 10-6 to 10-12 litres, using fabricated microchannels with dimensions in the 
sub-millimetre scale. Microfluidics was realised first in 1950s as a small droplet of liquids 
dispensed in nano- and sub-nanolitre scales [58], followed by a miniaturised ink jet printer 
nozzle that involved a gas chromatograph (GC) built on a silicon wafer; this was designed in 
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Stanford University in collaboration with IBM [59, 60]. Microfluidics enables the precise 
control of small volumes of fluids, and miniaturised fluid handling system is possible.  
The impact of microfluidic technologies in research has increased enormously in the last few 
years. Recent design development and utilisation of microfluidic devices for millilitre scales 
of fluid transport have been used in a variety of applications such as in life science industries 
for biomedicine and pharmaceuticals. This includes the development of drugs design, 
delivery and detection [61-63] and analytical devices such as point-of-care diagnostic 
devices (Figure 1.5) [64-66]. At industrial level, microfluidic technologies are used for rapid 
chemical analysis and high-throughput screening [67-69]. In biomedicine, demands for an 
implanted or ingested microdevice for non-invasive diagnostic and surgery have increased 
[70-72]. Other areas of application are in the transport of liquids and gases in aerospace [73, 
74]. Automotive engineering industries [75, 76] and microreaction engineering [77, 78] are 
interested in optical-based sensors [79-81]. 
Major advantages of microfluidics are the need to consume only a small quantity of fluids 
and reagents, with less hazard to the environment [82]. Microfluidics allows detection and 
separation at micron/nano spatial resolution; it is cost effective and only requires shorter 
trasport time for rapid analysis [83]. With the emergence of fabrication methods, 
microfluidics are able to differentiate the physical properties of fluids moving in large and 
small channels.  
In conjunction with the rise of microfluidics, there has been rapid development and 
fabrication of microdevices such as micromixers [84, 85], microvalves [86, 87], microsensors 
[88-90], microreactors [91, 92] and micropumps [93-95]. Each microdevice has specific 
functions and is a fundamental component in the realisation of a fully integrated 
microfluidic system, such as LOC or the micro total analysis system. An integrated functional 
microfluidic LOC system contains a number of different microdevices that achieve full 
automation in a single chip [96-98]. Particle transport processes such as reactions, mixing, 
separations and manipulation of particle at miniaturised scale are integrated and fully 
functional, producing high-throughput outcomes [99]. Microfluidics is the platform for LOC 
applications, offering a set of fluidic unit operations that allows the implementation of 
different applications in a well defined, low cost, fabrication technology [100, 101].  
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Figure 1.5 Three-dimensional microfluidic paper analytical devices (µPAD). (A) Fabrication is by 
stacking layers of patterned paper with double-sided adhesive tape. (B) Image of designed basket-
weave pattern 10 s after coloured dye solutions were added to the sample reservoir. Dotted line 
indicates the edge of the device. (C and D) Image taken at 2 and 4 min after adding the dyes. The 
fluids intersect each other on different planes without mixing. The dotted line in (D) represents the 
cross-sections shown in E, F and G. (E) Cross-section showing a channel connecting top and bottom 
layers. (F) Three layers of the device, consisting of orthogonal channels at the top and bottom layers 
of paper. (G) The distribution of coloured fluids in each layer of the device shown in D. Dotted lines 
depict the edges of the cross section. (Taken from reference [64]. Reprinted with permission from 
2008 ©National Academic of Sciences). 
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1.2.1 Promises of miniaturised analysis for biological sciences  
Recent developments in the design and application of microfluidic devices for fluid transport 
offer applications in pharmaceuticals and biomedicine, including life sciences. Microfluidic 
devices are becoming increasingly popular for applications across the biological sciences. 
They are useful because of their faster response time, their requirement of small fluid 
volumes, and their controllable flows at microscale [102]. Miniaturised LOC technologies are 
capable of (i) substantially reducing fluid volumes and operational costs [100], (ii) simplifying 
complex assay protocols [103-105]; (iii) precisely manipulating cell microenvironments to 
obtain high through-put outcomes [106-108]; (iv) providing scalability factors [109]; and (v) 
screening multiple batches simultaneously [110, 111]. Diverse microfluidic systems are 
making their way into biomedical research, from relatively simple functions to multiple 
analytical systems, and are used in wide range of applications including cell analysis, 
metabolomics, immunoassays and point of care diagnostics [105, 112, 113].  
Miniaturisation of LOC has led to a new approach to biological screening and 
experimentation. With the reduction of the number of uncontrolled parameters in a single 
experiment, a high number of different combination parameters can be examined. Its 
greatest potential lies in the physical components of the microscale transport system, which 
can utilise microfluidics to perform experiments that are not possible at macroscale, 
allowing new functionality and experimental standards to develop.  
1.2.2 Principles of microscale fluid flow  
The physics of fluid flow in a microfluidic system changes due to scaling factors. In fluid 
dynamics, the assumption inherent to the understanding of fluid mechanical behaviour is 
that the system will obey all the concepts of conservation laws including the conservation of 
mass, momentum and energy. Fluids are treated as continuous, under the continuum 
assumption, although in reality they comprise molecules. Measurable properties such as 
density, temperature and pressure vary from one volume to another depending on the 
molecular properties [114].  
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Fluids at microscale level do not flow at extreme velocities. The velocity at the boundary 
layer is assumed to be zero, with a non-slip condition. The motion of an incompressible 
Newtonian fluid flow through a control volume can be described by the simplified Navier 
Stokes equation:  
[
  
  
 (   ) ]               (1) 
where u is vector velocity, ρ is density of fluid, t is time, P is pressure, µ is dynamic viscosity 
and f represents the body forces (e.g. gravity ρgz, where gz is defined as gravitational 
acceleration).  
The left side of the equation represents the inertial acceleration per unit of volume. On the 
right of the equation defined as overall force per unit volume, due to the effects of viscosity 
and the pressure gradient. Viscosity in this context refers to the effectiveness of the 
momentum of the diffusion process, while inertia indicates the change in overall 
momentum of the fluid flow [114]. 
 
Figure 1.6 Laminar and turbulent flow streamline characteristics. 
There are two different fluid flow regimes governing fluid mechanics: turbulent and laminar 
flow (Figure 1.6) . Turbulent flow describes an irregular flow that forms eddies and vortices. 
This phenomenon can be explained using the inertial terms in the Navier–Stokes equation, 
the time-dependent acceleration (
  
  
) and convective acceleration (    ). Laminar or 
viscous flow, on the other hand, occurs when the streamline of fluid flow is smooth and 
parallel layers of fluid slide side by side without the creation of eddies and vortices. In 
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laminar flow there is no velocity component perpendicular to the main flow direction. It has 
a constant velocity at a given pressure difference from one end to the other, provided that 
the dimensions are constant throughout the system. 
Fluid behaviour is characterised by the magnitude of the inertial and viscosity terms. In 
laminar flow, the rate of momentum transfer (determined from the fluid viscosity) is high in 
comparison with the total amount of momentum (from inertial force). This is due to the 
suppression of the viscosity towards the flow acceleration. In contrast, when the total 
momentum rate goes beyond the diffusion momentum rate, a combination of the time 
dependent acceleration and convective acceleration leads to a turbulent regime.  
The flow regime can be characterised by the Reynolds number, RE, which gives the ratio of 
inertial to vicious forces. RE is a dimensionless quantity used to predict the flow patterns in 
different flow regimes: 
   
   
 
          ( ) 
where ρ is fluid density, v is the characteristic velocity of fluid, L is the characteristic length 
and µ is fluid viscosity.  
The RE equation depends on the geometrical shape of the channel in which the fluid flows. 
For flow in a cylindrical channel, the RE numbers are generally defined as: 
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where D is the hydraulic diameter of the channel (circular), ρ is the density of fluid, u is the 
velocity of fluid, v is the kinematic viscosity(  
 
 
), Q is the volumetric flow rate     
and A is the channel cross-section area. 
For a rectangular channel, the heights and widths of the channels are comparable and the 
hydraulic diameter is defined as:  
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where A is the cross sectional area and P is the rectangular perimeter. Laminar flow occurs 
when RE < 2100 and turbulent flow occurs when RE>4000 [115]. In the case of microscale 
channels in microfluidic system, the fluid flow is mostly in the laminar regime (RE<100) 
[116]. 
Molecular diffusion or mass transfer occurs when two or more fluids are mixed within a 
microfluidic channel. The transport phenomenon is characterised by a random thermal 
movement of the particles; the net movement is classified as movement from more 
concentrated to less concentrated areas (Figure 1.7). The diffusing particles are 
homogenised throughout a finite volume. Diffusion coefficients and distance of the mass 
transfer determine the time taken for a complete diffusion. Mass transfer in diffusion 
exhibits a potential delay that is not significant at the microscale level in a microfluidic 
channel width of less than 500 µm. The time interval of exchange fluid in mass transfer in 
microchannels takes several seconds to minutes.  
 
Figure 1.7 Mass transfer due to a steady diffusion within a microfluidic channel at the boundary of 
two laminar streams. 
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1.2.3 Fabrication methods for LOC devices  
A wide variety of methods was developed for the fabrication of microfluidic devices, 
including reactive ion etching [117], wet etching [118, 119], plasma etching [120], 
conventional tool-based machining [121, 122], hot embossing [123], laser ablation [124, 
125], photolithography and soft lithography. In the following sections, a brief description of 
some of the more common methods is presented. Table 1.2 presents the list of methods, 
with assessment of their cost, speed, and achievable feature size. 
Table 1.2. Comparison of microfabrication methods 
Method Material Cost Speed Feature size 
Conventional machining 
Metals, ceramics, 
polymers, composites 
High Fast < 200 µm 
Laser Micromachining 
Metals, polymers, 
ceramics 
Low Fast Variety 
Photolithography Polymers High Slow < 10 µm 
Soft lithography Polymers Low Fast < 10 µm 
Hot embossing Metals, polymers High Slow < 10 µm 
3D printing Metals, polymers Low Fast < 200 µm 
 
1.2.3.1 Material selection for fabricating chip-based devices  
Appropriate material selection is essential in the fabrication of microfluidic chip-based 
devices. Materials are generally chosen based on their suitability for a particular application. 
Critical issues such as thermal stability, mechanical behaviour, chemical properties, 
electrical characteristics, optical properties and biocompatibility are factors that need to be 
carefully considered in order to obtain maximum performance from a microdevice. 
In the early stages of the development of microfluidics, devices were fabricated on a silicon 
wafer or glass substrate [102, 126, 127], mainly because microelectronics and fabrication 
techniques were well established in the semiconductor industry. Glass materials have the 
advantages of outstanding corrosion resistance, optical transparency, dielectric 
characteristic, and good insulator; however, using it as a substrate material has significant 
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drawbacks: in particular, the complicated procedures required to manufacture it result in an 
expensive end product [126, 128]. Polymers such as polymethylmethacrylate (PMMA) [129-
131], and polydimethylsiloxane (PDMS) [132-134] are more promising materials for 
fabricating microfluidic devices because they have optical properties comparable with glass, 
and are in addition disposable, inexpensive, and with higher flexibility. 
PMMA, or acrylic, is an optically transparent material. It has excellent rigidity and 
mechanical characteristics, which make it is one of the dominant materials used for 
microfluidic device fabrication. Each PMMA sheet is non-porous and the surface exhibits a 
hydrophobic layer which reduces the contamination effect on the microfluidic operation 
[135, 136]. Although inert in neutral aqueous solution, it has low stability against alcohol 
and organic solvent which limits is use for some LOC applications [137].  
PDMS is currently the most widely used polymer material for LOC device fabrication. The 
polymer has excellent properties such as being optically transparent to light between 240 to 
1100 nm, and having thermal stability and and low surface tension [138, 139]. In 
microfluidic devices, where quantification of chemical substances are involved, the most 
important properties are permeability, elasticity and surface quality [140]. The porous 
nature of PDMS makes the material highly permeable compared with other elastomers; this 
enables small molecules to diffuse in the polymer, which makes it suitable for biological 
applications [132, 141]. The apparent permeability and biocompatibility make it the most 
suitable material for microfluidic devices designed to carry out the in situ biological 
experiment presented in this thesis. 
PDMS exist in highly coiled conformers, which makes them elastic. When the material is 
stretched the polymer unwind; when the tension is released, the polymer recoils. Elasticity 
depends directly on the amount of crosslinking, and during PDMS fabrication adding more 
or less curing agent to the elastomer base can alter this. The recommended ratio is 10:1 
(elastomer base:curing agent) by weight [126, 142]. Due to its flexibility, PDMS are used in 
microfluidic applications where materials need to be bent or twisted [143].  
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1.2.3.2 Conventional methods of fabricating LOC devices  
Standard available fabrication methods for microfluidic devices are not always suitable for 
fabricating LOC devices, and need to be carefully selected based the overall size of the final 
structures, material availability and cost of operation. In particular, the method chosen must 
be inexpensive and simple, as most LOC devices are fabricated in sophisticated laboratories 
with limited engineering facilities. This section briefly discusses the rapid microfabrication 
method of developing LOC devices.  
 Photolithography 
The most basic type of microfluidic fabrication is photolithography. Conventionally, 
processes involve silicon-based fabrication derived from semiconductor fabrication [144]. 
Photolithography employs patterns created by photosensitive material. A thin layer of 
photoresistant material is fabricated using a spin coater machine, then exposed to UV 
radiation through a photomask. After exposure, the areas that are more soluble in a 
designated solvent are removed and the remaining, more resistant structures remain on the 
substrate in the form of a negative [145]. However, this traditional method of lithography 
exhibits a low quality of transfer pattern due to insufficient flow of the polymer. This is due 
to the non-uniform size and placement of the desired structures on the mold. The method 
has a high replication precision of 99.5 % of the SU-8 layer, as illustrated in Figure 1.8.  
Mask-based lithography essentially imitates the features present on the mask, which is the 
primary structure. Complex structures required more time to fabricate and the cost of mask 
creation is considerable, so maskless photolithography is preferable for short-time 
microfluidic fabrication. This method uses a digital micromirror device that acts as a 
programmable mask and selectively reflects the incident light [146]. A small feature size in 
the sub-millimetre range, from 40 – 700 µm, is reliable for maskless lithography. Leigh and 
associates have developed a maskless micropatterning system that employs a fluorescence 
microscope with programmable X-Y stage and dry film photoresist. A scaffold template is 
fabricated for protein/cell patterning, or optically guided cell encapsulation for biological 
applications [147].  
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Figure 1.8 Process flow of the SU-8 microfabrication using photolithography techniques. (a) A 30 µm 
thick layer of SU-8 material is spin-coated on to a glass substrate. (b) Hot embossing is applied on 
pre-cured SU-8 at 85°C for 20 minutes in an oven. (c) The other side of the SU-8 layer is exposed to 
UV light using a UV mask at a dose of 227.6 µW cm-2 for 10 minutes. (d) Post baked at 85°C for 2 
minutes and the final structure is developed. (e) A layer of 20 µm thick of SU-8 is spin-coated on to a 
PDMS substrate, followed by post-baking at 85 °C for 30 s (f) The patterned SU-8 layer and the SU-8 
cover layer are thermally bonded in an oven at 50°C for 4 minutes. (g) The PDMS substrate is 
removed from the SU-8 cover layer and sealed micro and nano-channels are formed. (h) The sealed 
SU-8 channel is exposed to UV light to cross-link the SU-8 cover layer and inlets and outlets are 
formed. (Taken from reference [148]. Reprinted with permission from ©2014 Royal Society of 
Chemistry). 
 Soft lithography 
Soft lithography in poly (dimethyl methyl siloxane: PDMS) is the state-of-the-art microfluidic 
fabrication method. This method is time effective compared with silicon technology, 
requiring less than two days’ fabrication time. This technique is based on printing and 
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moulding, using patterned elastomeric stamps. Soft lithography enables control of the 
molecular structures of the surfaces, and fabrication of complex patterns is possible. This 
fabrication process is more convenient, inexpensive than conventional photolithography 
[149], and is most suitable for biological microfluidic devices. In addition, the process is 
maskless and it can save more time compare to the conventional lithography process. Its 
structure exhibits an inert surface that avoids adhesion with the protein and cells in the chip 
[142]. Khademhosseini et al. present a novel method for patterning cellular co-cultures 
using soft lithography to immobilise cells and protein onto a glass substrate without 
adherence to the surface, a method particularly suitable for fabricating controlled cellular 
co-cultures for cell–cell interaction studies and tissue engineering applications [150].  
Replication method from using a mould for patterning can be replicated many times in soft 
lithography fabrication. It uses rigid master moulds made from elastomeric material that 
facilitates the separation of master and replica or substrate. PDMS is widely used for this 
because of its rigidity, non-toxicity and commercial availability. It also has transparent 
properties, and its hydrophobic surface is permeable to nonpolar gases such as nitrogen, 
oxygen and carbon dioxide, which makes it suitable for biological samples [151]. A high 
aspect ratio of its structures such as nanopillars, 300 nm to 1 µm in diameter, are possible 
using replica moulding [152].  
Recently, Sticker et al. investigated an alternative material of elastomer, photosensitive 
thermoset (OSTEMER), used for multilayer fabrication of microfluidic devices. Three 
different membranes OSTEMER, flexible (FEP) and PDMS, enable the integration of 
microfluidic parts such as microvalves and micropumps [153]. 
 Laser micromachining 
Laser micromachining is a type of non-contact material removal process, mainly used 
industrially to create structures by direct machining. Laser beams spot scan the surface. 
Laser machining is an ablation process directed towards material substrate by absorption of 
the laser photons by the material, thus increasing its temperature and evaporation. The 
material’s removal occurs because of thermal mechanisms and laser interactions between 
materials. Laser micromachining has several advantages in the fabrication of complex cross-
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sectional shapes that are difficult to machine using conventional lithography processes. 
Multi-photon absorption is mainly from a transparent material if the intensity peak is high. 
This has been demonstrated by Darvishi et al. in the fabrication of tapered microchannels in 
borosilicate glasses and PDMS of transparent solids [154]. A Schematic diagram of the laser 
set-up is shown in Figure 1.9.  
 
Figure 1.9 (A) Schematic diagram of the experimental setup for laser ablation methods. (B) An image 
of the PDMS slab is oriented with the thin edge parallel to the laser beam. (C) Images of 
micromachined of trenches with different number of passes, N and stage velocity, V. (D) The 
micrographs of micromachined channels in borosilicate glass. (Taken from reference [154]. 
Reprinted with permission from ©2011 Elsevier Publishing Group) 
Ultrafast laser (pulse duration < 1 ps) interaction with material is different from 
conventional lasers. A non-linear mechanism is applied which is directly exert the energy 
coupling into the material, which is then ionised, and the bonds are broken directly by 
electron-photon reaction [155]. Recently, ultrafast laser machining has been used to 
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fabricate structures on thermal and shock-resistance materials, taking advantage of its high 
speed cutting using picosecond lasers. Both homogenous and non-homogeneous glass was 
machined using ultrafast laser  beams on a single-pass and single-shot configuration [156]. 
Post-processing of the machined surface is required, using a wet etching process to remove 
debris. 
The CO2-type laser depends on a discharge from a gas chamber filled with carbon dioxide, 
hydrogen, nitrogen and helium. The laser wavelength is around 10 µm. This laser is often 
used to fabricate microchannels in poly(methyl methacrylate)(PMMA) material [157]. Hong 
et al. have demonstrated direct laser machining of PMMA with a CO2 laser to fabricate 
microchannels with a width below 100 µm and depths from a few tens to a hundred 
micrometres. A high surface quality was observed: no post-processing is needed with this 
method [136]. The surface roughness is influenced by the grooves’ spacing and the 
orientation of the scanning direction between successive layers. Laser micromachining is a 
one-step process, but thermal damage around the cutting areas gives it inaccurate 
dimensions which limit its applications. 
Some of the techniques discussed above are labour intensive, require enough space to hold 
multiple pieces of equipment, need long processing times and use materials with limited 
biocompatibility. For example, photolithography technique consists of multiple steps, from 
selection of the material to fully functional chip, and this consumes considerable time. A 
more rapid fabrication method is preferred, particularly as some operators may not have 
the time to learn a complex fabrication process. 
1.2.4 Additive manufacturing: an alternative tool for microfabrication  
In recent research, the advancement of additive manufacturing or 3D printing technologies 
has simplified the fabrication of LOC devices by reducing the work to a single step. There are 
some remarkable advantages associated with 3D printing, including a low cost set-up, rapid 
prototyping, and a three dimensional (3D) digital design. 3D printing technology is currently 
the best solution to problems of more conventional methods of fabricating LOC device.   
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1.2.4.1 3D printing technologies 
3D printing is a rapid one-step manufacturing process, employing an additive layer-by-layer 
manufacturing process based on a sequence of cross-sectional slices from 3D model data. Its 
basic principle is much like that of a traditional laser printer or ink jet printer, but the multi-
coloured ink is replaced by polymer or resin. 3D printing consists of two main processes, 
design and fabrication. The first step in designing is to use  3D CAD or other engineering 
drawing software for full modelling of the structures. The printer able to configure the file 
format and sliced into 2D sequential cross sections slices depending on the resolution (layer 
thickness) of the printer. At the end of the process, the printer deposits layer by layer of 
polymer or resin and form a complete 3D structures.  
Several different methods employ the 3D printing concept: stereolithography (SLA), Multi 
Jet Modelling (MJM) and fused deposition modelling (FDM), and all are well established in 
prototyping microfluidic devices [158]. The factors that determine the quality of printing are 
layer by layer thickness (accuracy), printing speed, type of materials and build size. 3D 
printing technologies currently used to fabricate microfluidic devices mainly use 
photopolymer resin as the build material, to make the channel directly for the sub-sequence 
process of replica moulding. 
 Stereolithography (SLA)  
The SLA fabrication process, also known as micro-stereolithography (µSLA), is one of the 
available 3D printing technique, that can create fine structures [159]. It was first established 
by Hall in 1986, creating a layer-by-layer 3D object from photosensitive liquid solidified on 
exposure to ultraviolet (UV) light [160]. SLA allows rapid and easy fabrication of functional 
prototypes, and does not require any production tooling prior to printing. The basic 
principle is the use of structured light such as a laser beam to scan the surface of resin that 
polymerises and solidifies upon exposure to UV. Conceptually, a thin layer of curable resin is 
stacked parallel and on top of another when printing takes place. The platform moves down 
in the z direction after one layer is printed, and this process is repeated until the whole 
structure is formed. A liquid bath of curable resin is used on top of the movable stage. 
During the process, the table is lowered each time by a distance that determines the resol 
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layer thickness of the printer. An optical scanner scans the laser beam across the curable 
resin in the x and y planes. Both bath configuration and optical set-up are convenient, 
implementable set-ups [161] (Figure 1.10).  
 
Figure 1.10 (A) Schematic diagram of configuration SLA printer with direct write-curing process 
fabrication. The stage is submerged in liquid resin. The laser moves along the surface of the resin 
and polymerises the resin row by row until the desired layer is completely cured. The stage is 
submerged lower into the resin tank until a new layer of liquid resin covers the surface and the 
polymerisation repeats. (B) Schematic diagram of a configured SLA printer with a projection-based 
curing method. In this configuration, the stage is submerged at a specific distance in the resin 
reservoir. In the projection curing method, the digital mirror permits a whole layer to be cured at 
once. The stage can be elevated by a defined distance and another layer cured. This process repeats 
until the complete object is printed. (Taken from reference [161]. Reprinted with permission from 
©2014 American Chemical Society). 
In SLA, the cure depth determines the z axis resolution (layer thickness), which is controlled 
by the photoinitiator and irradiant exposure conditions such as wavelength, power and 
exposure time. UV absorbers are available for the fabrication of transparent or optical grade 
parts. The layer thickness is usually within the range of 50–200 µm; with 
microstereolithography, however, resolutions up to 5 µm can be achieved [162]. 
One of the advantages of using SLA fabrication is the fine precision of the feature resolution 
up to 50 µm. SLA systems have become the most widely used and commercialised form of 
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3D printing [163], but in other applications, are able to fabricate structures at low cost due 
to the low usage of the liquid medium. SLA adapts to a variety of monomers and resins as 
material parts of the liquid medium. The monomers used in photopolymerisation-based 
part-printing have a low viscosity that is capable of rapid polymerisation and produces 
cross-linked polymers. With fast curing monomers and short radiation exposure time, the 
photoinitiator that remains able to be post-cured in an UV oven to complete the curing 
process [164].  
The 3D printer has become smaller and more affordable since its first commercialisation; it 
is likely to reach a stage where it can print structures even at home [165]. For example, the 
Form1+type high resolution (25-100 µm) developed by FormLabs company is a type of 
personal desktop SLA model able to print structures that achieve industrial standards at an 
affordable price. It can  print structures up to 25 µm thick with a minimum feature size of 
300 µm [166].  
SLA is heavily used in areas as diverse as engineering, manufacturing and art [167]. Its high 
precision printing has attracted researchers to apply the technology in biological and 
medical sciences. The use of additive manufacturing technologies in bone tissue engineering 
has gained much interest in recent years, and 3D printing was found a suitable method of 
printing porous scaffolds with good surface quality [168]. A study conducted in 2009 by Lan 
et al. fabricated a 3D porous scaffold from poly (propylene fumarate: PPF) polymer using 
µSTL with a porosity of 65%. Results found that using a biomimetic coating on the scaffold 
can be useful in bone tissue engineering [169]. In addition, a well defined 3D model of 
porous structures has been successfully prepared with SLA, using poly(d, l-
lactide)/nanosized hydroxyapatite (PDLLA/nano-Hap) composite resins [170]. 
 Digital micro-mirror device based projection printing (DMD–PP)  
DMP–PP technology uses the same working principle as SLA, but has a controllable digital 
mirror that can reflect the laser light into the entire plane to cure the full layer at once. This 
is unlike the standard SLA system, where the laser is used to scan the shape of the printing 
object. Unwanted printing areas are digitally masked by the DMD–PP system [171]. Unlike 
SLA, DMP-PP does not require the movement of the printing stage because the focal 
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configurations can be automatically adjusted by the tilting convex lens in the system [172] 
(Figure 1.11). This technology has improved the printing time, and is considered to be the 
next advancement of SLA [173].  
 
Figure 1.11 Schematic diagram of DMD-PP system configuration. (Taken from reference [172]. 
Reprinted with permission from ©2012 Elsevier Ltd.). 
 Two-photon polymerisation (2PP)  
Two-photon polymerisation is a direct writing technology which uses femtosecond laser 
pulses to write the design into the photosensitive resin. The process is similar to SLA in that 
the pulse laser activates the polymerisation process of the resin [174]. In this process, two 
photons are absorbed simultaneously by the photo initiator and act as one photon for the 
polymerisation reaction to begin. This allows the process to write directly any 3D patterns 
into a volume of photosensitive resin. Most of the materials used are transparent, near-
infrared and highly absorptive in the UV spectral range. 2PP technology allows the laser 
beam to be focused by adjusting the laser pulse energy and the number of applied pulses. 
This improves the printing resolution thickness up to 150 nm by providing a smaller laser 
beam diameter of 10-200 µm; however, the writing or tracing method is slower than SLA 
[112].  
 Fused Deposition Modelling (FDM)  
FDM is a method for rapid prototyping, which depends on surface chemistry, thermal 
energy and layer-by-layer technology [175]. Thermoplastic materials such as polycarbonate 
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(PC) are melted in a heating element to a semi-solid condition. This melted polymer is 
extruded through a nozzle onto a platform table, layer by layer. The table moves upwards as 
the extrusion process continues, and as it moves the melted material solidifies to form a 
complete model, as illustrated in Figure 1.12 [176]. Recent developments have shown that 
FDM has great potential in clinical applications[177], tissue engineering [178, 179] (Figure 
1.13) and diagnostic platform [180]  A wide range of materials can be used in FDM, such as 
carbon fibre reinforced plastic (CFRP), to improve physical properties such as tensile 
strength and the flexural properties of the prototypes [181]. FDM is cheap and reliable for 
prototyping substrates and mass production; however, the lines of the layers can be seen on 
the surface of the prototype, and may affect the final structures of the product [182].  
  
 
Figure 1.12. Schematic diagram of FDM basic principles. Heated nozzle directly extruded polymer 
and layer by layer polymer is deposited on the platform. (Taken from reference [176]. Reprinted 
with permission from ©2015 Academy of Dental Materials). 
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Figure 1.13 Different biodegradable polymers scaffolds for tissue engineering were fabricated using 
FDM method. All the structures were characterized using scanning electron microscope (SEM). 
(Taken from reference [179]. Reprinted with permission from ©2012 Wiley Periodical Publishing 
Group). 
 Multi Jet Modelling (MJM) 
MJM is a type of contactless printing technique capable of reproducing digital image data on 
the substrate materials using picolitre droplets. This process is similar in concept to 
commercial ink jet printers; the main difference is that the material used instead of ink 
prints photoresin or wax material. The heads release material onto the tray and where it is 
cured by UV light and solidified. After this the build tray is lowered and building the next 
layer begins. This fabrication process is fast, produces a high quality final product, and is 
able to print with multiple materials simultaneously [183] (Figure 1.14). 
MJM can be used to deposit conductive tracks based on organic silver particles and copper 
precursors. Due to their high surface-to-volume ratio, the use of nanoparticles reduces the 
sintering temperature in order to render the conductive tracks [184]. Park et al. have 
demonstrated a direct-wired MJM using copper nanoparticles of 40–50 nm to fabricate 
metal-like patterns that are highly conductive after undergoing heat treatment [185].  
MJM has shown great potential in various applications, including electronics and 
biomedicine. For example low-cost lithium microbatteries are fabricated using ionogel, 
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which gives the batteries a liquid-like electrolyte performance [186]. Traditionally, this is 
done using a physical vapour deposition technique, which is more expensive and time-
consuming. Interestingly, Caro et al. explored the possibility of MJM by printing a film 
consisting of chitosan-tripolyphosphate nanoparticles (CS/TPP); this film is used as 
packaging to extend the life of fresh fruit [187]. 
 
Figure 1.14 Photopolymer-based ink-jet printer using the MJM fabrication concept (Taken from 
reference [183]. Copyright 2008 CustomPartNet). 
 
Figure 1.15 Schematic configuration of the selective laser sintering process (Taken from reference 
[188]. Reprinted with permission from ©2016 PAGEPress). 
 Selective laser sintering (SLS). 
Direct selective laser sintering is a powder-based layer-additive rapid-prototyping process. 
The laser beam is used as the heating element for scanning, and as the powder melts, it 
forms predetermined shapes [188, 189] (Figure 1.15). As the first layer is scanned, a second 
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layer of loose powder is deposited on the surface; and the heating process is repeated from 
bottom to top layer until the structure is complete. This technology has a great advantage of 
direct printing using metals, while other printers are limited to polymers or plastics. Unlike 
resins, metals and ceramic powders are incompressible structures, so no additional support 
material is needed to print overhanging structures; however, post-processing is needed to 
remove residue from small and narrow structures [190]. 
 Bioprinting  
Recent advances in additive manufacturing technologies have enabled 3D printing of 
biological materials such as cells to be placed in the printer and dispense it layer by layer to 
form a complex functional living tissues. Customised 3D printer scaffolds for tissue 
generation or organ engineering can be fabricated using bioprinters [112]. However, 
challenges remain in the integration of a vascular network, because engineered tissue does 
not get a sufficient supply of nutrients and gas exchange during perfusion [191]. Bioprinters 
vary significantly between manufacturers, and each printer is designed for specific biological 
materials such as cells, agarose, hydrogels or other viscous biocompatible materials [192, 
193] (Figure 1.16).  
 
Figure 1.16 Image representation of agarose template fibers bioprinting and the formation of 
microchannels using the micromolding technique. (A) A bioprinter attached with a piston fitted 
inside the glass capillary extracts the agarose mixture (inset image). (B) A hydrogel is cast over the 
bioprinted mould and solidified. (C) The template is removed from the solidified hydrogel. (D) 
Perfusable microchannels are formed. Inset image shows microchannels perfused with a fluorescent 
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microbead suspension (pink) (scale bar is 3 mm, microchannel diameter is 500 µm) (Taken from 
reference [193]. Reprinted with permission from ©2014 Royal Society of Chemistry). 
3D printing fabrication has advantages and limitations. Every printer has different 
applications and uses different materials. Table 1.3 presents the characteristics of the 3D 
printing technologies described in this chapter.  
Table 1.3 Comparison of 3D printing technologies 
3D  
printing 
Material (s) 
Resolution 
(µm) 
Speed Cost 
Special feature 
(s) 
Surface 
finish 
SLA[159, 160, 
162, 164, 165, 
167, 173] 
Photopolymer 
resins 
<100 
Mediu
m 
Medium High resolution Smooth 
DMD–PP [161, 
172, 173] 
Photopolymer 
resin 
<100 Fast Medium Rapid fabrication Smooth 
2 PP [112, 174] 
Photopolymer 
resins 
<100 Slow High 
Ultra precise 
resolution  
Smooth 
FDM [175-182] 
Thermoplastics, 
Polycarbonate, 
>200 Fast Low 
Inexpensive, 
desktop size, and 
wide range of 
materials 
Rough 
MJM [183-187] Photopolymer <100 
Mediu
m 
Medium 
Multiple 
materials used 
Smooth 
SLS [188-190] Metal, Polymers <100 
Mediu
m 
Medium 
Metals used 
(option for 
investment 
casting) 
Rough 
Bioprinting 
[112, 191-193] 
Cells, DNA <100 Slow High 
Biological 
materials 
Smooth 
 
1.2.4.2 Applications of 3D printing in microfluidics  
In comparison with conventional microfabrication methods, 3D printing features capability 
in fabricating high-resolution (up to 16 µm) complex structures with a single step in an 
inexpensive fabrication process. Recent advances and development have spurred growing 
interest in biological and biomedical fields, and this has led to investigations into 
applications of this technology in fabricating microfluidic and LOC devices. 
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 Interconnection ports 
Common techniques used to interconnect microfluidic devices with other instrumentation 
are inserting tubing into punched holes or using adhesive to seal the tubing onto PDMS 
slabs. However, lack of reliability in the connection ports can cause a device failure due to 
leakage and back pressure. The use of 3D printed features can solve this problem by 
integrating a connection mechanism that can not be achieved in the traditional soft 
lithography technique. For example, Lee et al. have successfully integrated threaded ports 
that fit commercial finger-tight adapters with 3D printed microfluidics for more reliable and 
convenient connection with external tubing [194]. In addition, with multimaterial 3D 
printing, O-rings can be printed directly onto microfluidic devices to create tight seals and 
connections [195] (Figure 1.17 A). Customized 3D printed luer adapters and threaded 
fittings have also been reported [196] (Figure 1.17 B).  
 
Figure 1.17 Examples of 3D printed connectors. (A) Rubber-like 3D printed O-rings can be placed on 
a microfluidic device. The printed O-rings are used to connect different microfluidic chips. (Taken 
from reference [195]. Reprinted with permission from ©2014 The Royal Society of Chemistry). (B) 
3D printed luer adapters on a microfluidic device for easy connection to syringes and tubing. (Taken 
from reference [196]. Reprinted with permission from John Wiley & Sons, Inc.).  
 Complex flow microfluidic components 
Efficient and precise flow control of fluid is an important factor when designing microfluidic 
devices. At microscale, fluids exhibiting laminar flow may cause insufficient mixing between 
reagents [197]. Chip mixing mechanisms have previously been integrated into microfluidic 
devices through a complex fabrication [198, 199]. With the capabilities of 3D printing, a 
microfluidic device with complex structures can be fabricated in a few steps. For example, 
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Lee et al. adapted SLA technologies to develop 3D printed channels with a turn- and-twist 
pattern, including a separate unit to mix the flows for alpha-fetoprotein biomarker 
detection. It has proved that microfluidic devices may be printed in a straightforward, rapid, 
and user-friendly way [194]. Bonyar et al. designed a microfluidic device, printed using MJM 
technologies. The prototype is used to transport cervical samples from the clinic to the 
laboratory. The printed device comprises a mixer and homogeniser for gynaecological 
cervical sample preparation [200] (Figure 1.18). 3D printed pumps and valves for fluid 
handling and manipulation have also been reported [201, 202].  
 
Figure 1.18 Microfluidics prototype for cervical sample preparation contains fluid mixer and 
homogeniser. Two reservoirs are used to store the reagent and the sample separately and can be 
released using fingertips for mixing (Taken from reference [200]. Reprinted with permission from 
©2010 Elsevier Ltd.). 
 On chip device for cells and organism integration  
Application of microfluidic technologies for in situ analysis of cells and small model 
organisms are attracting a growing interest. Although a number of cells and organisms-on-
chip have been reported [203-205], 3D printing technologies are able to enhance the 
complexity, versatility and reusability of models. Takenaga et al. used an SLA 3D printer 
(Asiga, Picoplus 27) to directly fabricate a microfluidic unit, and assembled it on a light-
addressable potentiometric sensor (LAPS) chip for cell culture [203]. An optimised cell 
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culturing was achieved within the printed microfluidics-based LAPS chips by adjusting the 
foetal calf serum concentrations of the cell culture medium. The cell growth curve showed a 
comparable result between the culturing cells in a printed chip and in a cell culture flask. For 
a small batch series of chips for cell culture, 3D printing is promising, offering a rapid and 
cost-effective design of a new sensor. However, studies on the biocompatibility of printing 
resins are still in development. 3D printing resins are being developed that are expected to 
be non-toxic to cells [168] (Figure 1.19 A). 
Zhu et al. have demonstrated the feasibility of a range of 3D printers from SLA and MJM 
systems to print directly the millifluidic chip device for culturing zebrafish embryos. SLA 
technologies show superior resolution and feature quality compared with MJM 
technologies. Selected SLA polymers have optical properties enabling high resolution 
imaging with 50 MHz pixel digitization [166]. However, most printed chip devices have been 
found to be semi- transparent, and require labour-intensive polishing to make the outside 
device transparent and smooth. The inner wall of the fully sealed channel cannot be 
polished, and it is almost impossible to observe the inside channel without additional 
treatment (Figure 1.19 B). 
 
Figure 1.19 (A) LAPS chip with microfluidic channel connections. (Taken from reference [203]. 
Reprinted with permission from ©2015 John Wiley & Sons Inc.).(B) Chip-based prototypes for using 
Watershed resin. Inset image is the optical transparency assesment during embryo immobilisation. 
(Taken from reference [166]. Reprinted with permission from ©2015 AIP Publishing LLC). 
 Master mould fabrication for soft lithography 
Conventionally, soft lithography involves using high resolution up 150 nm of photomasks 
and exposing the photoresist materials to UV radiation to create a positive master mould; 
this involves challenging tasks such as aligning the layers of photoresist [206]. In addressing 
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problems, several researchers have reported using conventional machining such as high 
speed micromilling to create durable metal master moulds [121, 207, 208]. However, this 
method is not always convenient as tool wear and breakage are critical issues in tool-based 
micromachining. 3D printing technology is an innovative alternative that allows greater 
control of complex 3D geometry than conventional microfabrication with a minimum 
feature size of 100 µm. 
The capabilities of 3D printing are not yet fully developed, even in experimental works 
where flexibility and speed are essential. 3D-printed structural elements have only been 
applied in several experiments, such as for oral surgery [209, 210]. Although 3D printing is 
capable of directly printing microfluidic devices, Zhu et al. have highlighted significant 
biocompatibility issues with the resins currently available for 3D printing [211], a large 
majority of which are toxic to biological specimens. This precludes the fabrication of 
monolithic millifluidic devices and their applications with living cells, tissues and small model 
organisms [166].  
With the development of higher-resolution (up to 25 µm) printers, 3D printing is now used 
to fabricate millifluidic and microfluidic structures such as master moulds for soft 
lithography processes, which can now be created using one step printing. Additionally, 3D 
printing of a mould does not require a mask to be fabricated as in conventional soft 
lithography process, where 3D printing directly fabricates the mould. The overall cost of the 
fabrication process therefore is reduced and the several steps required to pattern the 
master mould in soft lithography are simplified. 
Different 3D printers such as SLA and MJM have been used to fabricate master moulds. Each 
printer is investigated and its characteristics noted prior to PDMS fabrication in soft 
lithography (Figure 1.20)[212, 213]; the examination considers the printer’s ability to 
replicate dimensional accuracy, shape conformity and surface feature [212]. The moulds are 
then applied to several applications such as pneumatic balloon actuators for robotic 
applications [214], mixers and peristaltic valves [215], and capillary channels [216]. The 3D 
printed moulds enable rapid prototyping of structures, unattainable in existing soft 
lithography techniques. 
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Figure 1.20 Design of microfluidic devices for the generation of microliter droplets-in-oil and the 
formation of droplet arrays with interdroplet lipid bilayers. (A) The channels (1.10 mm wide x 0.55 
mm deep) are cast in PDMS using 3D printed mould. The oil inlets are in yellow and the aqueous 
inlets in red and green. A delay line for lipid monolayer formation is in orange, and the droplet 
capture chamber is blue. (B) The droplet capture chamber comprises a rail for droplet positioning. 
(C) The measured values (bold) are compared with CAD design values (italic). (Taken from reference 
[213]. Reprinted with permission ©2013 Royal Society of Chemistry).  
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1.3 Fish-on-chips: chip-based technologies for zebrafish research  
Small model organisms assays that utilise zebrafish are still performed in multi-well 
microtiter plates and are laborious and time consuming [217]. The conventional static 
microenvironment of the embryos may limit the compounds available to the organisms 
because of surface adsorption, degradation and other factors [218]. Lammer et al. have 
improved the model by introducing a flow-through system in which the conventional 24-
well plate is modified with drilled holes [218]. Although the overall cost of fabrication is low, 
the procedure is complex and time consuming. Even when applied, the liquid surface 
tension limits the imaging acquisition as upright imaging is difficult to achieve, so even with 
this improvementthe system does not offer proper miniaturisation and automation. 
Apart from improvement to the conventional microtiter plates, innovative designs using 
microfluidic technologies which are able to improve automation with simplified 
methodology have been demonstrated. A variety of microfabrication and microfluidic LOC 
devices have been developed for the phenotyping and screening of zebrafish embryos and 
larvae.  
1.3.1 Culturing embryos on chip-based devices  
The microfluidic-based culture of zebrafish at the embryonic stage has been developed from 
semi-manual devices to recent automated and integrated platforms. Microfluidic segment 
technique was first introduced in 2007 by Funfak et al. using perfluoromethyldecalin (PP9) 
as the carrier liquid and Teflon (PTFE) as the tube material in the shape of a coil [219]. 
Embryos were transferred from a microtiter plate by means of a syringe pump. The team 
used an ingenious method of air bubbles to provide fluid segment stability. Fluid flow and 
image acquisition were controlled by dedicated software. The effects of copper on zebrafish 
embryo survival and physiological development were observed inside a specially created 
segment [219]. Although the segmented flow system with integration of the image platform 
was capable of achieving high levels of automation, there were significant limitations on the 
imaging platform. The coil-shaped Teflon tube inhibited the quality of the imaging. 
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Two years later, a PDMS-based microfluidic bioreactor for zebrafish was developed by Shen 
etal. [220]. A funnel-shaped aperture immobilised the embryos and the chip was submerged 
in a Petri dish containing fish medium that incorporated a gravity-driven pump to deliver the 
test substance through the microchannels. However, the embryos were still manipulated 
manually within the aperture using a pipette, limiting throughput. 
Later, several chip-based flow-through systems were developed that were integrated with a 
concentration gradient generator [221, 222]. Photolithography was used to fabricate several 
layers of glass plates consisting of embryo culture chambers. The medium solution and drug 
delivery via a concentration gradient generator were perfused by a controlled syringe pump. 
However, complex and uneconomical fabrication techniques using photolithography were 
used to fabricate the devices, and the laborious manual handling of the embryos limited the 
throughput of the systems. 
 Hydrodynamic influenced embryo trapping arrays  
With the development of microfluidic devices, manual procedures were still needed to load 
embryos into the miniaturised chip devices, making them vulnerable to damage as the 
embryos, in an early stage of development, were extremely fragile. To overcome this 
limitation a miniaturised chip device was developed capable of loading embryos without 
human intervention. 
Akagi et al. was the first to design and developed a microfluidic devices that implemented a 
hydrodynamic embryo array concept for automated trapping, immobilisation and on-chip 
perfusion of zebrafish embryos as illustrated in Figure 1.21 [27]. The serpentine design of 
the microchannels allowed the hydrodynamic forces to guide the embryos inside one of the 
embryo traps. With the flow generated in the channels, sufficient drag was generated to 
immobilise the embryos once they were trapped, and could sustain long-term 
immobilisation for up to 72 hours. The recovery of the embryos from the device was by 
pumping the medium from the outlet [27]. The conceptual design of the traps and the 
twisted flow channel created an orderly trapping of embryos without affecting the trapping 
efficiencies. A similar chip design was also fabricated using additive manufacturing 
technologies, using multiple 3D printers with different polymer materials [166]. 
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Figure 1.21 Assessment of microenvironmental conditions of zebrafish embryos cultured inside the 
chip: (A) Three-dimensional streamline flow across the fully loaded device; (B) The shear stress (Pa) 
contours exerted on each embryo across the entire device. Perfusion was simulated at a flow rate of 
0.4mL/min; (C) The performance curve of the microfluidic device as a function of the volumetric flow 
rate; (D) Time-lapse images of zebrafish embryo development inside the device. (Taken from 
reference [27]. Reprinted with permission from ©2012 PLOS one Publishing Group). 
 
In the continuing work of this group, Akagi et al. developed a microfluidic device for real-
time analysis of the transgenic zebrafish embryos [223, 224]. A U-shaped heating manifold 
surrounded the trapping area, designed to maintain the temperature throughout the 
embryos’ development. Each embryo was gravitationally docked in the designed traps, 
which connected to a suction channel controlled by a piezoelectric ultrasonic pump. This 
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design offered a rapid fabrication with an automated embryo manipulation and perfusion 
system.  
Recently, a PDMS chip-based design of a microfluidic platform with integrated fluidic 
actuation was developed. A microvalve system was embedded to pneumatically control the 
fluid flow using actuators [225]. With this system, renewable fluid manipulation can be 
achieved within ten seconds. Although the device is still under development, the microvalve 
design is a promising concept for well-controlled fluid delivery applications. 
1.3.2 Culturing larvae on chip-based devices  
In contrast to embryos that exhibit uniform spherical geometry, eletheuro-embryos or 
larvae have a non-uniform shape; their swimming bladders offer a challenge to real-time on-
chip imaging, creating problems associated with larvae immobilisation and high metabolic 
rates. 
Conventionally, anesthetised zebrafish larvae were mounted onto agarose gel in a Petri dish 
[226-229]. Recently, with the advancement of 3D printing technologies, a homeostatic chip-
based platform for zebrafish larvae immobilisation was developed with a customised 
agarose mounting configuration [230]. Moisture and heat can be controlled via circulating 
buffers and heated water at the bottom of the agarose strip set-up, to control the 
homeostatic condition of the larvae. With this newly developed configuration, imaging of 
hundreds of larvae simultaneously can be achieved. Although its methods are affordable, 
manual orientation of the larvae on the agarose is, as always, laborious and time-
consuming, and controlling the orientation of the larvae is also difficult and tedious. 
To solve the orientation problem, an agarose-free larvae immobilisation system was 
developed to allow imaging in either lateral or dorsal orientation [231]. The Zebrafish 
Entrapment by Restriction Array (ZEBRA) microfluidic device was developed and fabricated 
using both PDMS and polystyrene. The device consists of two layers: the top layer, a 
mechanically machined fluidic channel for larvae holding chambers; and a bottom layer as 
the sealing base. The chamber is designed to enable both orientations of larvae. The loading 
procedure is assisted by a passive pump drive (surface tension-driven) towards the docking 
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position. Although the low-cost chip in its design facilitates high resolution of 800 lines/mm 
imaging of zebrafish larvae, manual handling is still needed.  
Later, Akagi et al. developed a proof-of-concept LOC device to immobilise zebrafish larvae 
for environmental scanning electron microscopy (ESEM) imaging, using infrared laser 
micromachining of the PMMA substrate [232]. Multiple semispherical microwells were 
designed for the specimen reservoir to hold the yolks of the larvae. Gentle suction by 
blotting the medium is used to trap and immobilise the larvae, which can be linearly aligned 
and immobilised in a simple configuration (Figure 1.22). Although this approach avoids 
extensive preparation procedures, manual blotting to hold the larvae is still not convenient 
in high-throughput imaging procedures.  
 
Figure 1.22 Schematic representation of the process involved for the zebrafish larvae immobilisation 
chip-based device (Taken from reference [232]. Reprinted with permission from ©2014 International 
Society for Advancement of Cytometry). 
The next step to hydrodynamically trapping the larvae was to develop a PDMS microfluidic 
chip-based device for a fish trap array that immobilised intact larvae at dorsal and lateral 
positions simultaneously developed by Lin et al. [233]. Several trapping channels are linearly 
arrayed to trap and immobilise the larvae, each designed to fit the tail of the larvae. The 
microfluidic devices are designed to facilitate tail-forward trapping. A direction-switching 
loop in the system adjusts the alignment of the larvae before loading them to the chip 
device. The larvae are transferred by a capillary-based syringe pump coupled to a triggered 
electronic valve. High-speed photodetection confirms the loading of the larvae and 
determines the tail direction [233]. This configuration reduces the level of human 
intervention, but although the system suits high-throughput applications, the set-up is 
complex and the overall cost is high.  
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In 2016, Hong et al. presented an integrated zebrafish analysis platform (iZAP) for long-term 
high-throughput electrophysiological monitoring [234]. The system comprises a PDMS 
microfluidic unit, multielectrode array and integrated electronic unit amplifiers. The 
microfluidic unit is designed as an open chamber with a large inlet pool where zebrafish 
larvae (5–7 dpf) swim freely. The trap channels are shaped as half cylinders, with one end 
open and gradually tapering to a half cone. When zebrafish are loaded they spontaneously 
swim along the channels and are restrained inside. The custom-built multichannel head 
stage amplifiers are integrated with surface microelectrodes directly in contact with the 
zebrafish heads to obtain continuous electroencephalogram (EEG) signals during drug 
treatment. This integrated microfluidic system greatly facilitates electrophysiological 
monitoring of zebrafish models. IZAP demonstrates a non-invasive and long-term approach 
to electrophysiological imaging using vertebrate epilepsy models, but the fabrication 
process is complex, particularly where it involves photolithography procedures for the 
PDMS microfluidic unit. Schematic configurations of the system is illustrated in Figure 1.23. 
 
Figure 1.23 Integrated zebrafish analysis platform (iZAP) for high-throughput electrophysiological 
monitoring configurations. (A) Schematic diagram of design concept. Inset image represents the 
position of surface electrodes to the zebrafish brain. (B) An illustration of integrated system of the 
microfluidic platform. (C) Images of trapped zebrafish larvae in the iZAP microfluidic unit. (D) An 
image of the iZAP system placed inside an optical-windowed Faraday cage. The red fluid represents 
the zebrafish medum (Taken from reference [234]. Reprinted with permission ©2016 Macmillan 
Publishers Limited). 
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1.3.3 High content analysis on chip-based devices  
Due to the unique characteristics of zebrafish, they are mainly used in sophisticated 
screening or analysis to assess the physiological effects of a chemical substance in living 
vertebrates. Their transparency, which makes it easy to collect numerous data points in a 
single organism using high quality imaging with 640 x 480 pixel resolution, makes them 
suitable for high-throughput screening and high content analysis. High content analysis 
encompasses a fully automated manipulation, imaging and data processing system to collect 
detailed information from the organisms. The integration of an automation platform system 
provides a higher level of content analysis from in situ screening. 
To improve the microfluidic chip-based zebrafish embryo culture system, an innovative 
integrated laboratory automation system was developed and demonstrated by Wang et al. 
[235]. A microfluidic actuator, temperature regulator and image acquisition system were 
integrated in a single automated system, designed to perform automatic immobilisation, 
culture and chemical treatment of the developing embryos. The integrated units were 
controlled by Field Programmable Gate Array (FPGA), a microcontroller that enables real-
time control of the embryos. 
Akagi et al. reported an advancement to the high-content-analysis chip-based platform by 
adding a separate drug delivery manifold with miniaturised piezoelectric pumps to enable 
embryo loading and drug delivery [236]. A servomotor-actuated pinch valve is used to 
control drug delivery; and an optically transparent indium tin oxide (ITO) heating element 
replaces the previous flow-through heating system [236]. For imaging acquisition, a 
miniaturised fluorescent USB microscope equipped with LED illumination is used. This fully 
automatic system allows suitable visual imaging of developing vasculature patterns in 
response to treatment, without the need for specimen re-orientation. 
The same group later developed an innovative high-throughput flow-through chip-based 
device for zebrafish embryo trapping arrays [237]. The device is able to trap and immobilise 
up to 252 embryos in a flow-through embryo-culturing device for real-time imaging. The 
hinge-like cradle manifold provides an interface between the tubing and the connection 
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ports to avoid leaking and air bubbles, and therefore does not require for manual insertion 
of the connection tubes.  
1.3.4 Application of LOC devices for zebrafish in drug discovery  
Modern drug discovery depends on automatic screening to evaluate the efficacy of the test 
candidates, cytotoxicity, and possible side effects of the drugs. Because of their low 
consumption of samples and reagents, microfluidics have been applied in cell-based 
bioassays and the phenotyping of multicellular organisms [238]. They have also been used 
to evaluate drug dosage dependence on-chip, to test compound toxicity and evaluate cells’ 
dynamical behaviour [239].  
Zebrafish have been used to study the pharmacological effect of drugs. Microfluidic LOC 
technologies offer advantages over conventional microtiter plates for culturing zebrafish 
embryos and larvae. It provides non-invasive culture conditions and high quality imaging 
(640 x 480 pixel resolution), as well as the ability to access the embryos at any 
developmental stage [240]. It is an ideal platform for on-chip cultivation and manipulation in 
preclinical drug discovery applications. It is widely adopted because it is reproducible, 
economical, amenable to modification, and can be integrated with other technologies [241].  
1.3.4.1 Assessment of cytotoxicity  
Microdevices offer great opportunities to develop new drugs and to assess the effects of 
toxicity on the tissues and cells of zebrafish embryos or larvae. Phenotype-based 
evaluations can be performed to determine the toxicity measurements of drug candidates, 
similar to morphologically-based cytotoxicity assessments. Yang et al. proposed a 
microfluidic system to investigate the toxicity and teratogenicity of doxorubicin, cisplatin, 
vitamin C and 5-flurouracil (f-FU) on the phenotype characteristics of the zebrafish embryos 
[221]. The toxicities of the drugs were evaluated based on observations of such things as 
pigmentation, heart rate, body motion and shape, development of notochord, and tail and 
fin morphology. A dose response curve for doxorubicin was plotted at different stages of 
development. The drugs had irreversible and fatal side effects [221].  
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A microfluidic embryo array was also used to perform preliminary toxicity tests for analysis 
of heavy metals dissolved into the zebrafish medium. Akagi et al. performed a flow-through 
perfusion toxicity test using copper solution [236]. The fatality or mortality rate of the chip 
perfusion set-up was significantly higher than that in static FET experiments. The continuous 
perfusion capabilities shown in microfluidics technologies, permitted a rapid exchange of 
the copper solution [236], indicating that microfluidic devices can be readily applied to 
perform FET assays on zebrafish embryos. 
Later the same group automated the zebrafish embryo µFET test using microfluidic LOC 
technologies [242]. A continuous flow-through perfusion system was implemented to test 
drugs such as phenol, nicotine, caffeine and copper sulphate on immobilised zebrafish 
embryos. Results of the dose response curve achieved from the chip-based system were 
comparable with the static protocols performed in microtiter plates [242]. The work proved 
that FET analysis performed in a microperfusion system can be an inexpensive protocol in 
aquatic ecotoxicology. 
1.3.4.2 Assessment of cardiotoxicity  
Drug-induced cardiac dysfunction leads to high mortality. Zebrafish have been used to study 
the toxicity of chemicals on cardiac development and function. Zebrafish embryos develop 
rapidly, and heartbeat starts 22 hours post-fertilisation (hpf) and is fully functional at 48 hpf, 
exhibiting a complex repertoire of ion channels and metabolic processes [243]. Medium 
throughput assays for cardiotoxicity analysis based on morphological endpoint toxicity have 
been developed where cardiovascular changes are visually assessable without dissection 
[244]; these cardiotoxicity studies have been useful in understanding the impact of specific 
toxicants on heart function [244-248]. 
Using microfluidic LOC technologies in the assessment of cardiovascular drug effects gives 
researchers the ability to control the fluid flow conditions such as shear stress and flow rate. 
The small volume of fluid used in microfluidics system is suited to monitoring the effects of 
drug administration on organisms such as zebrafish embryos, making microfluidics 
advantageous for studies of cardiovascular physiology because of their amenability to 
pharmacological modifications [249]. Although microfluidic technologies are still evolving, 
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there are some works already reporting on the use of microfluidics as a platform for 
cardiotoxicity studies using zebrafish. 
In 2014, Li et al. a microfluidic system for a phenotype-based evaluation of the toxicity and 
teratogenicity of drugs, using zebrafish [250]. Developmental stages were evaluated by 
changes in physiological indicators such as heart rate, hatch rate, survival rate and 
morphological measurements. The heartbeat was quantitatively measured for 20 seconds at 
24, 48, 72 and 96 hpf. The study showed that higher concentrations of aminophylline (Apl) 
resulted in faster heartbeat and the fish suffered from pericardial oedema. Cardio-vascular 
assessment of drug-treated embryos is an important stage in embryonic cardiac 
developmental toxicity studies. 
1.3.5 Limitations of current chip-based systems for zebrafish research  
Laboratory microfluidic automation of in situ analysis using zebrafish embryos and larvae is 
still in its infancy. Besides, manual procedures associated with sorting hundreds of embryos 
are very monotonous and as such prone to significant analytical errors due to operator 
fatigue. The major obstacle to the widespread deployment of zebrafish in large-scale drug 
development studies is the lack of efficient high-throughput analytical platforms. In general, 
zebrafish embryos are collected and separated manually to sort the fertilised (live) from the 
unfertilised (dead) ones, or to sort transgenic from non-transgenic clones before loading to 
the microfluidics. Laborious manual evaluation is required to confirm fertilisation status, 
viability, or the presence of a transgene linked to a fluorescent protein. Subsequent 
dispensing of single developing embryos to multiwell plates to perform toxicity analysis is 
also predominantly manual, prone to errors and inter-operator variability [251]. In addition, 
manual techniques introduce the risk of cross-contamination and carry-over that can 
significantly affect the outcome of drug discovery screenings. 
Although zebrafish embryo sorters such as CellBot and ZebraFactor are available, these 
systems are large, complex, and expensive [252]. There is also a lack of chip-based LOC 
microfluidics available for sorting zebrafish embryos. A miniaturised, reliable and user-
friendly embryo chip-based device for embryos sorting is still unavailable.  
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Recently MacDonald et al. investigated the biocompatibility of various resins of 3D printers 
with zebrafish embryos [253]. The results showed that all photopolymer resins were toxic to 
the embryos, causing fatality. The fabrication of chip-based devices using a printed mould is 
advantageous for zebrafish culture compared to direct printing of a chip-based device. 
Currently few studies use microfluidic platforms using zebrafish embryos for cardiotoxicity 
studies. The microfluidic system developed for dynamic cardiotoxicity studies overcomes 
the limitations of using microtiter plate [250], but still relies on a manual count of the 
heartbeat readings, which is not suitable in high-throughput analysis. Moreover, several 
hatched embryos are placed in one chamber, which makes the data prone to error. 
Most recent studies have focused on zebrafish embryos with the chorion still intact. There is 
a possibility of generating false negative results in developmental toxicity studies because of 
the limited permeability of the chorions to certain compounds. It is suspected that the intact 
chorion influences chemical uptake and in some cases is a barrier to metal nanomaterials 
[254, 255]. Dechorionation of the embryos can overcome this [256]. Despite microfluidics 
evolving, there is a lack of development in the design and fabrication of a reliable 
microdevice for dechorionated embryos.  
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2  Aims and Objectives 
The research herein is aimed as a step towards the development of a microfluidics LOC 
system able to handle zebrafish embryos and larvae for drug discovery and environmental 
research. No currently available method provides a reliable platform for automated 
immobilisation, long term perfusion culture, quality imaging and analysis in a single low-cost 
and robust microfluidic system. For this reason, the goal of this thesis is to develop 
microfluidic and millifluidic devices to address the problem described in Chapter 1. The 
thesis objectives are as follows:  
i. To develop a proof-of-concept design for micromechanical large particles in a flow 
sorter that is capable of detecting, sorting and dispensing living zebrafish embryos 
for drug discovery applications 
ii. To design and develop a PDMS chip-based millifluidic device capable of trapping and 
immobilising living zebrafish larvae for recording heart rate variations in 
cardiotoxicity analysis, using methods available with new, improved soft lithography. 
iii. To develop a microfluidic LOC device for trapping and immobilisation of 
dechorionated embryos for long-term microperfusion for ecotoxicology 
experiments.  
In this thesis, Chapter 3 describes the general materials and fabrication methods of 
zebrafish LOC devices and experiments. This is followed by a description of the development 
of microdevices for detection methods to distinguish between live and dead embryos, in 
Chapter 4. Chapter 5 describes new approaches made possible by soft lithography to 
fabricate the design of millifluidic devices for trapping and immobilising zebrafish larvae. 
Finally, a microfluidic device for the immobilisation of dechorionated zebrafish embryos is 
described and presented in Chapter 6. The thesis concludes with a summary of the potential 
impact of this work for biomedical communities, and offers a consideration of future 
development in Chapter 7.  
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3  Materials and Method 
This chapter describes the materials used in the experiments, including test chemicals for 
the biological tests and materials for device fabrication. The methodology associated with 
the research is also presented. This chapter describes procedures for animal culture, 
prototyping, data acquisition and analysis. All procedures and steps taken in the 
experiments are discussed in detail.  
3.1 Chemicals and materials 
3.1.1 Chemicals for toxicity tests  
Caffeine (C0750; CAS No. 58-08-2; 194 mol weight), lead acetate (CAS No: 546-67-8; 443.38 
mol weight), phenol (CAS No: 108-95-2; 94.11 mol weight), verapamil hydrochloride (V4629; 
CAS No. 152-11-4; 491.06 mol weight) and propranolol hydrochloride (CAS No: 318-98-9; 
295.8 mol weight) were purchased from Sigma-Aldrich, Australia. Copper sulphate 
pentahydrate CuSO4.5H2O (CAS No: 7758-99-8; 249.68 mol weight) was purchased from 
Thermo Fisher Scientific, Australia. All were in powder form. Chemical solutions were 
prepared by dissolving solids in E3 media in volumetric flasks with serial dilutions.  
Nicotine (N3876; CAS No. 54-11-5; 162 mol weight) and dimethyl sulfoxide (DMSO) 
(W387520; CAS No. 67-68-5; 78 mol weight were obtained from Sigma-Aldrich (St. Louis, 
MO, USA) in liquid form. All other chemicals were of the highest quality and provided by 
local suppliers. All vehicle controls were prepared by adding DMSO in E3 media.  
3.1.2 Low melting point agarose for zebrafish mounting  
Mounting plates were prepared by adding a small volume of 1.5% agarose (Carl Roth) in E3 
to half-fill the 90 mm Petri dishes, and stored at 4°C. The mounting agar was prepared by 
melting 0.5-1.5% of low melting point (LMP) Agarose (Sigma Aldrich) in E3 media. 1.5 ml of 
each aliquot of fresh mounting agar was kept at 37°C in a liquid heat bath. 
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3.2 Zebrafish husbandry and culture  
All animal research was carried out with approval from the RMIT University Animal Ethics 
Committee and Monash University Animal Ethics Committee.  
Adult wild type zebrafish embryos (Danio rerio (AB line; Zebrafish International Resource 
Center, Eugene, OR, USA) were kept in a temperature- and light-controlled aquaculture 
facility in a standard 14 hour light, ten hour dark cycle. The zebrafish were fed with artemia 
twice daily. Embryos were obtained by mating four to five pairs of adult zebrafish for natural 
spawning; on average, this generated 200–300 embryos These were collected and washed 
of all debris, transferred to a petri dish and maintained in an incubator (Thermo Scientific, 
Heratherm TM Advanced Microbiological Incubator) at 28.5±0.5 °C in embryonic E3 medium 
(5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, 0.1% methylene blue), and 
observed the stages of embryonic developmentof the zebrafish. 
A few zebrafish embryos of 12 and 24 hpf (hours post-fertilisation) stages were loaded in an 
embryo sorter and dechorionated chip devices. Larvae of 3 dpf (days post-fertilisation) were 
used for a larva immobilisation experiment. This research was conducted with approval 
from the Royal Melbourne Institute of Technology Animal Ethics Committee (approval AEC 
1404). Healthy fertilised embryos were seen to be clear and transparent after collection, 
while dead embryos were black and opaque in colour as shown in Figure 3.1. 
 
Figure 3.1 Images of (A) Live zebrafish embryo at 12 hpf and (B) 24 hpf zebrafish embryo (C) Dead 
embryos. Bar scale is 400 µm. 
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3.3 Dechorionation Methods  
Mechanical Dechorionation  
Dechorionation was carried out on 24 hpf embryos in 90 mm glass Petri dishes filled with E3 
medium. The chorions were removed with sharp sterile needles (Terumo Medical 
Corporation, Terumo®, Japan) by gently incising a lit along the chorion. The needle enlarged 
the slit and turned the chorion upside down until the embryo fell out (Figure 3.2 A–F). It is 
important to make a big enough incision for the embryos to leave the chorion without 
damaging the edges of the chorion. Excess pressure should also be avoided to avoid any 
injury to the embryo. After dechorionation, all embryos were carefully placed in agarose-
coated 90 mm glass Petri dishes with polyethylene transfer pipettes (Livingstone, Australia) 
with an end opening diameter of 1.8 mm. 
 
Figure 3.2. Mechanical dechorionation using sterile needles (Terumo ®) (A) Intact zebrafish embryo 
24 h post-fertilisation; (B) Zebrafish embryos held with one needle (C) A small incision in the chorion 
with the needle (D) Second needle enlarges the slit by in the chorion (E) The chorion is turned upside 
down to allow the embryo to fall out from the chorion (F) dechorionated embryo. Bar scale is 500 
µm. 
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3.4 Acute toxicity test (LC10 determination) for cardiovascular toxicity  
All stock solutions were prepared in E3 mediums and serial dilutions were carried out before 
the experiments. The toxicity analysis was performed using the standard protocol (OECD 
236) guidelines. Twenty zebrafish larvae at 3 dpf were transferred into each petri dish 
containing 40 ml of E3 medium. The petri dishes were covered with parafilm and incubated 
at a constant temperature of 27 ± 0.5°C. These procedures were carried out in darkness to 
protect the compounds from light-induced decomposition. Dissolved oxygen was kept 
above 80% during the experiment. After the 24-hour treatment in the petri dishes, the 
mortality curve was plotted and a 10% lethal concentration (LC10) was calculated by probit 
analysis ToxRat software (ToxRat Solutions, Alsdorf, Germany). This concentration was then 
used to assess cardiovascular toxicity. 
3.5 Fish Embryo Toxicity and Sublethal Embryo Toxicity Index (iFET)  
A static Fish Embryo Toxicity (FET) analysis was performed on 24 hpf dechorionated 
embryos according to the  the standard protocol (OECD 236) [257]. Twenty four 
dechorionated embryos were transferred into 24-well plates with one embryo per well. 
Each well contained 2 ml of positive control (3,4-dichloroaniline), negative control (E3 
medium) and test concentrations. The plates were covered with adhesive foil and incubated 
at 27 ± 0.5°C. The lethal and sublethal end points were determined according to standard 
protocol and recorded every 24 hours. 
A non-static chip-based perfusion FET was carried out using a millifluidic chip-based device 
and a modified static standard protocol. Twenty dechorionated embryos at 24 hpf were 
loaded onto the microfluidic array. The chip-based devices were perfused in a closed loop 
system with a volumetric flow rate of 1000 µL/min, attached to an external stock of test 
concentrations in 50 mL falcon tubes, via polytetrafluoroethylene (PTFE) tubing 1.3 mm in 
diameter. The embryos were immobilised and incubated up to 72 hours at 2.7 ± 0.5°C in a 
dark environment. 
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3.5.1 End point scoring criteria for FET. 
Precise observations of toxicity were performed based on four lethal end-points: (i) 
coagulation of fertilised embryos, (ii) lack of somite formation, (iii) non-detachment of the 
tail from the yolk sac, and (iv) lack of heartbeat. The toxicity was recorded with a positive 
score for any of the end-points listed. All the scored data were used to calculate the median 
lethal concentration (LC50) [257].  
3.5.2 End point scoring criteria for the Sublethal Embryo Toxicity Index 
A set of calculations newly developed by Wigh and colleagues increases the sensitivity of 
conventional FET scoring criteria by including sublethal and teratogenic conditions [258]. 
There are nine additional sublethal endpoints as toxicity indicators: (i) abnormal and 
disturbance of eye development, (ii) formation of oedema, (iii) blood circulation deficiency, 
(iv) lack in pigmentation (v) abnormalities in tail formation, (vi) abnormalities in head 
formation, (vii) abnormalities in spine formation, (viii) abnormalities in yolk formation, and 
(ix) heart abnormalities. All sublethal toxicity experiments were recorded every 24 hours for 
72 hours in the experiment.  
The sublethal toxicity index was quantified using the formula:  
     
(    )     
   
      
where N = total number of embryos, ND = number of dead embryos (FET-mortality end 
points), and NSL = number of sublethal indicators recorded according to the nine listed 
scoring criteria at the end of the experiments. The iFET results were calculated as a 
percentage of dechorionated embryos showing both lethal and sublethal abnormalities.  
3.6  Computational fluid dynamics (CFD) analysis and simulation  
Optimisation of fluid flow of the chip design was guided by CFD simulations using COMSOL 
Multiphysics® Software (COMSOL Inc., MA, USA) to create the geometrical and mesh 
generation. A flow rate between 1000–2000 µL/min at the inlet pressure to be 0 Pa at the 
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outlet were implemented. Boundary conditions were set to non-slip conditions at all 
surfaces, top, bottom and sidewalls, of the channels. 
3.7 Multi-layer 3D chip fabrication  
The 3D chip was designed and fabricated using Computer Assisted Design (CAD) packages 
including CorelDraw X4 (Corel Corporation, Canada) and Solidworks 2013 (Dassault Systems 
SolidWorks Corp, Concord, MA, USA). Subsequent prototyping and fabrication was 
accomplished using a contactless 30 W CO2 laser cutting system equipped with high-power 
density focusing optics (HDPFO)TM (Universal Laser Systems, Scottsdale, AZ, USA) at 50 µm. 
A biocompatible material of poly-methyl methacrylate sheeting (PMMA/Acrylic), which is a 
transparent thermoplastic, was precisely laser cut in a range of 0.5–3.0 mm thickness to 
build integrated channels and trapping regions. 
Each layer of sorter was stacked vertically and thermally bonded at 110°C for up to two 
hours in a fan-assisted oven (Thermo ScientificTM, HERAthermTM, General Protocol Oven, 
USA). The PMMA layers were aligned with a precision measuring tool, L-square. A uniform 
mechanical force was applied with two mini clamps to provide a constant force over the full 
surface during bonding. The PMMA sheets were then positioned between two aluminium 
plates (5 mm thick) that allowed the transfer of heat to the contact surface. Bonding 
pressure was adjusted by controlling the loads applied to the top of the plate. Direct laser 
machining of apertures achieved tubing inter-connections of 2.9 mm (outer diameter), 
capable of incorporating the 1/16-inch PTFE tubing (Cole Palmer Instrument Company, 
Vernon Hills, IL, USA) and permit free passage to zebrafish embryos and larvae.  
3.8 Additive manufacturing of off-chip interfaces  
All the prototype casings were designed and fabricated using fused deposition modelling 
(FDM) (Makerbot Replicator, Brooklyn, NY, USA) (Figure 3.3). High quality PLA thermoplastic 
with high tensile strength was made with a resolution up to 200 µm of layer thickness. The 
CAD designs were saved in the STL (standard stereolithography) format for printing. Printed 
support structures of the end product were removed manually with specialised removal 
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equipment. The extruder nozzle was heated to 110°C before printing. The table platform 
was calibrated before any printing took place. 
 
Figure 3.3. Illustration of FDM equipment for prototyping (Makerbot Replicator, Brooklyn, NY, USA) 
The system was connected to an external high-precision multichannel Miniplus Evolution 
peristaltic pump equipped with a MF1 pump head (Gilson Inc, Middleton, WI, USA) using 
PTFE 1/16-inch tubing. Calibrated PVC tubing (1.3 mm diameter; Gilson Inc.) was fitted in a 
cartridge to accommodate the required range (1000–2000 µm) of flow rate. All devices were 
primed with 100% ethanol (v/v) in advance for wetting purposes and to eliminate the 
formation  of air bubbles. Chips were filled up with the standard E3 fish medium. 
3.9 Fabrication of polymeric mould for larvae immobilisation devices  
3.9.1 3D printed master mould  
In this research, ProJet HD 7000 (3D Systems Inc., USA), Objet Connex 350 (Stratasys Ltd.) 
and Form1 (FormLabs, USA) were used for fabrication of the master mould (Figure 3.4). 
With these 3D system printers, VisiJet SL CLear polymer was used for both substrate and 
support because it can generate a fine lattice beneath the substrate to create the support 
structures. VeroClear was used as the base material. For Objet Connex 350, FullCure705 was 
selected for the substrate material and Support 705 for the support materials. Both contain 
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an acrylic oligomer and a photoinitiator that cures under UV light as it prints. FormClear 
polymer resin was used both as base and support material in Form1 printer, and no other 
support material needed. Each printer uses different processes to form 3D prototypes, as 
detailed in Table 3.1. All printing used the same parameters, such as 100 µm of layer 
resolution.  
 
Figure 3.4 Additive manufacturing technologies. (A) Stereolithography (SLA) ProJet HD7000 with a 
maximum build volume of 380 mm x 380 mm x 250 mm; (B) Multi jet machining (MJM) Objet 
Connex 350 with a net volume of 342 mm x 342 mm x 200 mm; (C) Desktop SLA printer Form1 with a 
maximum build volume of 125 mm × 125 mm × 165 mm. 
Table 3.1 Configuration of 3D printing of polymer larvae chip 
Company Model Technology Materials 
Accuracy 
(x–y 
resolution) 
Layer 
thickness 
(z–resolution) 
3D Systems 
ProJet 
HD7000 
SLA 
VisiJet SL 
Clear 
25 µm 25 µm 
Stratasys 
Objet 
Connex 350 
MJM Vero Clear 25 µm 16 µm 
FormLabs Form1 SLA Form Clear 20–85 µm 16 µm 
 
Post processing was needed to remove all the supports printed to hold the overall shape of 
the design (Table 3.2). All the printed moulds were treated with solvents such as isopropyl 
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alcohol to clean the surface, and water jet cleaning washer (PowerBlast, Kranzle, Germany) 
was used carefully to remove support materials (Figure 3.5 A). Next, radiation treatment 
using electromagnetic UV (ProCure 350, 3D Systems Corporation, USA) was introduced for a 
minimum of 30 minutes to ensure all resins solidified completely and to improve the clarity 
of the printed surfaces (Figure 3.5 B). This process also enhanced the tensile strength of 
each mould so a good quality of structure could be fabricated using replica moulding with 
PDMS. 
Table 3.2 Post-processing treatment for different 3D printers 
Model 
Post Processing Treatments 
Solvent Water Jet Cleaning Compressed air UV Curing 
Projet 
HD7000 
Isopropyl 
alcohol 
No Yes 30 minutes 
Objet 
Connex 
350 
Isopropyl 
alcohol 
Yes Yes 30 minutes. 
FormLabs 
Submerged in 
isopropyl tank 
for 10 minutes 
No Yes 6 hours 
 
 
Figure 3.5 Post processing treatment to remove support materials from 3D printed parts (A) High 
pressure water jet system manually used at 50-60 Barr to clean the supports (B) UV radiation curing 
process to increase the clarity and tensile strength of printed parts.  
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3.9.2 PDMS casting  
The bonded PMMA master mould was used for replica moulding in 
poly(dimethylsiloxane)(PDMS; Sylgard 184, DowCorning Corp, Midland, MI, USA) [126]. The 
PDMS was prepared at a ratio of 10:1 (w/w) of elastomer base to curing agent and then 
degassed at 40 Torr for 30 minutes in a vacuum chamber using a dessicator with 6.4 mm of 
internal diameter tubing port. A high voltage alternating current (HVAC) high performance 
rotary pump (VacuMaster 3CFM Vacuum Pump, Robinair, MI, USA) was connected with a 
desiccator to remove any residual air bubbles in the PDMS mixtures as shown in Figure 3.6. 
 
Figure 3.6 A set-up for degassing method. The PDMS mixture (sample) was placed inside a 
desiccator. A high-performance vacuum pump was connected to the desiccator by means of a 
rubber hose 
The PDMS mixture was poured in a master mould as illustrated in Figure 3.7 to achieve a 
substrate thickness of approximately 5 mm, and degassed in a sealable vacuum desiccator 
for 20 minutes to clear air bubbles, then cured thermally at 70°C for two hours. Cured PDMS 
was peeled off the mould, mechanically diced, and bonded to 76.2 mm x 25.4 mm x 1.1 mm 
standard glass microscope slides using oxygen plasma surface activation (Harrick Plasma, 
NY, USA). Microfluidic connections were manually bored using an appropriate stainless steel 
biopsy punch of 3.0 mm diameter (Paramount Surgimed Ltd, New Delhi, India). Both PDMS 
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and glass-topped surfaces were exposed with plasma for approximately four minutes inside 
the chamber. 
 
Figure 3.7 Step-by-step process of PDMS fabrication: (A) Curing agent mixed with Sylgard 84 at a 
10:1 ratio (B) Printed moulds are fixed to a rectangular mould (85 mm x 35 mm x 10 mm) (C) The 
mixture is carefully poured into the mould and degassed to remove air bubbles (D) Degassed mixture 
is cured inside a fan-assisted oven for two hours, before being separated from the printed mould 
manually. Bar scales are 12 mm. 
3.10 Imaging 
Time lapse imaging of the embryos and larvae on the chip-based device were performed 
using Nikon SMX18 (Nikon Corp., Tokyo, Japan) equipped with a Retiga TM 4000DC cooled 
CCD camera. The stereomicroscopic system was controlled by a built-in software package 
(NIS-Elements Ar) for image analysis. All visual and image acquisitions of the acute toxicity 
test were observed under the dissecting stereomicroscope. A miniaturised Universal Serial 
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Bus (BUS) microscopy (AMT7013MT Dino-Lite Premier, Dino-Lite, AnMo Electronics Corp, 
New Taipei City, Taiwan) with a rate of 60 frames per second, was used for imaging and 
video recording. 
All scanning electron microscopy images were taken using a FEI Quanta 200 ESEM (2002) 
operating at 30 kV and spot size of 5.0 in high vacuum conditions. Before being loaded into 
the scanning electron microscopy, samples were coated with Au/Pd using an in-house 
sputter coater operating at 15 mA for one minute. All optical profilometry images were 
analysed with a non-contact surface profiler, BRUKER ContourGT-I Optical Microscope with 
stitching mode enabled. A USB microscope (Dino-Lite) with a backlight was also used in 
embryo and larvae observations.  
Video recorded files of zebrafish cardiac activity were analysed using DanioScope (Noldus 
Information Technology, Netherlands). Each file was converted into an MPEG 4 (MP4) audio 
file before analysis. 
3.11 Sensing module using differential infrared optical density (DIOD)  
The primary detection module enabled oscilloscopic identification of differential infrared 
optical density (DIOD) by employing infrared (IR) emitters and receivers embossed in the 
microfluidic chip, as shown in Figure 3.8. 
  
Figure 3.8. Sensing module set-up for DIOD method. A peristaltic pump was used to load embryos at 
a flow rate of 1500 µL/min. A digital microscope (Dino-Lite) was used for embryo imaging. A single 
channel of a PMMA microfluidic chip was fabricated to test the viability of the embryos using DIOD. 
Inset shows a magnified view of the infrared sensors embedded in the channel. Live mbryos were 
stained with Trypan blue dye solution. 
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3.12 Image recognition requisition using Roborealm  
Real-time video tracking of embryos was performed using RoboRealm (Machine Vision) 
software. Dead embryos were detected and tracked in real time based on a colour and blob 
algorithm to filter their image intensity as a population of embryos moved in single file 
inside the microfluidic channel. A miniaturised USB bright field and polarisation microscope 
(AM7013MT Dino-Lite Premier; AnMo Electronics Corporation, New Taipei City, Taiwan) was 
used in proof-of-concept experiments to acquire a video stream at 30 frames per second. 
Specimen illumination was provided by eight integrated ultra-bright white LEDs controlled 
by dedicated software (DinoCapture2.0; AnMo Electronics Corporation). The miniaturised 
USB microscope was powered and controlled through a USB2.0 interface with an external 
PC computer running the Windows 7 operating system (Microsoft, Redmont, WA, USA). The 
video stream from AM7013MT Dino-Lite Premier was fed via a USB2.0 interface to a PC 
running RoboRealm software. 
3.13 Actuation of sorting receptacle  
Precise control over the rotational movement of the sorting receptacle was realised with a 
Dynamixel AX-12A robotic actuator (Robotis Ltd). The AX-12A actuator had a torque of 16.5 
kgcm and no-load speed of 0.196 sec/60° at 12 V, with a maximum current of 900 mA. The 
AX-12A robotic actuator was controlled by a CM-530 microcontroller (Robotis Ltd) based on 
32-bit ARM Cortex M3 architecture. The programming was performed in a native RoboPlus 
environment (Robotis Ltd). 
3.14 Data analysis and controls  
Toxicity data was analysed using ToxRat (ToxRat Solutions GmbH, Alsdorf, Germany). All 
data illustrations and presentations were performed using GraphPad Prism 7 (GraphPad 
Software, Inc, USA) software packages. A standard one-way analysis of variance (ANOVA) 
model was applied to perform independent comparisons for each toxicant concentration, 
with significance at p<0.05. All experiments were performed at least twice, with three 
independent replicates per concentration tested unless otherwise indicated. 
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4  Proof-of-concept Design of Microfluidic 
Device for Embryo Sorting 
4.1 Introduction  
At present, the major hurdle to widespread deployment of zebrafish embryos and larvae in 
large-scale drug development projects is the lack of analytical platforms enabling high 
throughput. To spearhead drug discovery with the use of zebrafish as a model, platforms 
need to integrate automated pre-test sorting of organisms (to ensure quality control and 
standardisation) and their in-test positioning (suitable for high-content imaging) with 
modules for flexible drug delivery. The major obstacles to the sorting of millimetre-sized 
particles such as zebrafish embryos on chip-based devices are their substantial diameter 
(above one millimetre) and mass (above one milligram), both of which lead to rapid 
gravitational-induced sedimentation and high inertial forces. 
Zebrafish embryos are encapsulated by chorion described as an acellular envelope 
surrounding the mature eggs with a diameter ranging from 1.0–1.2 mm. Furthermore, each 
of the embryo approximately has a mass of 850 µg to 1050 µg. Thus, it permits gravitational-
induced sedimentation force, high linear and angular momentum of the moving embryos in 
the fluid flow in the sub-millimetre sized channels. Therefore, this was initially a challenge in 
handling process of the embryos in a microfluidic system. However, in this research, these 
characteristics were utilised as for proof-of-concept method in embryo sorting principle.  
In this chapter, I present an innovative proof-of-concept design of a micromechanical large 
particle in-flow sorter that capable of analysing, sorting and dispensing living zebrafish 
embryos for drug discovery applications. The system consisted of a microfluidic network, 
revolving micromechanical receptacle actuated by robotic servomotor and opto-electronic 
sensing module.  
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4.2 Chip design and fabrication  
The microfluidic circuitry comprises a main inlet and outlet channels with a rectangular 
cross-section of 1.6 mm (width) x 3.0 mm (height) for embryo loading and sorting, as 
illustrated in Figure 4.1 A. The main part of the chip is housed with the sorter wheel, which 
is an embedded revolving micromechanical receptacle 19 mm in diameter with an embryo 
trap engraved by a laser in raster mode to a depth of 1.8 mm (blue dotted circle, Figure 4.1 
B–C). The embryo trap has semicircular geometry with a diameter of 1.5 mm and an 
opening of 1.25 mm. 
A mounting hole of 3.0 mm (diameter) x 2.0 mm (depth) is laser machined in the middle of 
the receptacle and a polymer bearing is press fitted to facilitate the smooth rotation of the 
receptacle. Eight neodymium magnets of 3 mm (diameter) x 2 mm (thickness) and a 
strength of 1.32 Tesla are embossed in the receptacle to enable non-contact actuation by an 
external servomotor (Figure 4.3 C). 
The miniaturised sorter comprises four layers of PMMA (Figure 4.2), cut using high 
definition laser micromachining. The top layer (thickness = 2.0 mm) consists of the circular 
holes (Ø = 2.9 mm) for inlet and outlet channels. The second layer, 3.0 mm thick, contains 
the main loading channel for embryos and the outlet channels. The third layer contains a 
circular cut (Ø = 20 mm), 35.16 mm from the inlet channel. Both second and third layers are 
3.0 mm thick. The fourth layer (60 mm x 25 mm x 1.5 mm) is used as the bottom sealant 
layer for an enclosed microfluidic system.  
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Figure 4.1 Overview of 3D chip-based in-flow embryo sorter (A) Detailed CAD drawing showing the 
details of the main loading, inlet and outlet channels. (B) Multiview projection of sorter wheel 
embedded with a polymer bearing and eight pairs of Neodymium magnets. (C) Fabricated 
biocompatible PMMA sorter chip that connects to tubing with an outer diameter of 3 mm. Live and 
dead embryos are separated via two outlet channels.  
 
Figure 4.2 An exploded view of the microfluidic device in the sorter. The function of each 
independent layer is noted. The layers of PMMA are aligned and thermally bonded to form a 
permanent seal. The red dotted box contains an exploded view of the sorter wheel, consisting of 
neodymium magnets and polymer bearings. 
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The prototype of the miniaturised sorter was fabricated using both infrared laser 
micromachining and fused deposition modelling (FDM). The design consists of four main 
modules: i) the microfluidic 3D chip formed by four independent layers of PMMA (Figure 
4.2), ii) embedded revolving micromechanical receptacle, iii) 3D printed external interface, 
and iv) electronic control panel, (Figure 4.3). The 3D printed housing was designed to hold 
the chip and servomotor in alignment. 
 
Figure 4.3 Built-in microcontroller in the 3D printed housing used to position the shaft to direct 
embryos from the inlet to the outlet channel. Bar scale is 20 mm.  
4.3 Zebrafish embryo sorting concept  
The design of the device harnesses hydrodynamic forces to move the embryos in a passive 
flow from one channel to another. Computational fluidic dynamics (CFD) simulations, 
initially performed (COMSOL Multiphysics v4.4) to predict flow velocity, pressure drop and 
uniformity of mass transfer inside the device, indicated that at a perfusion rate of 1500 
µL/min, flow velocities inside the chip varied from 0.0028 m/s to 0.0016 m/s, at input and 
output respectively. Higher velocity (red streamline) was observed in the main loading 
channel as simulated (Figure 4.4). This enhanced the momentum of the embryos moving 
towards the trap. The trap had a constant flow of 0.0037 m/s. A circular flow around the 
receptacle had an average velocity of 44 x 10-6 m/s that provided sufficient suction to 
immobilise the embryos inside the trap as depicted in Figure 4.4. 
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Figure 4.4 A coloured plot 3D simulation of fluid streamlines across the microfluidic chip with 
velocity (m/s) profile obtained from CFD simulations. The red dotted inset depicts the flow at the 
embryo trap as the embryo enters the main loading channel. The flow profile is symmetrical because 
of the laminar flow in a microfluidic system. The blue arrow represents the flow direction inside the 
chip. 
In the sorting process, the mechanical receptacle is designed to capture the embryo and 
place it into the appropriate channel. The fluid streams inside the microfluidic chip were 
validated experimentally when the sorter receptacle was positioned at different angles 
relative to the outlet channel from the main loading channel. The rotation of the receptacle 
towards the outlet channels changed the flow conditions, enabling embryos to be recovered 
from the trap (Figure 4.5). The dimension allowance between the sorter wheel and the main 
loading channel enabled the fluid to flow from the inlet to the outlet channel at a velocity of 
0.0075 m/s. The position upwards has a velocity of (0.00050 m/s) and downwards has a 
velocity of (0.00055 m/s). These give sufficient force to hold the embryos while the 
receptacle moves to the outlet channel. 
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Figure 4.5 Visual illustration of the flow switching principle. The simulated fluid streamlines in the 
sorter trap are at angles 0°, -45° (downwards), and + 45° (upwards) (AC). The device is perfused with 
0.04% of Trypan blue dye for imaging, and has a volumetric flow of 1500 µL/min. The experimental 
condition is comparable to the simulation and depicted in images (D–F). Blue arrow represents the 
fluid flow inside the microfluidic chip. 
Next, the mass transfer uniformity inside the microfluidic device was predicted and 
validated experimentally using a dyed solution as the model probe. The chip was primed 
with ethanol solution during the experimental validation stage to eliminate air bubbles, 
followed by flushing with the fish embryo medium. The simulation showed that the medium 
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exchange rate reached 100% within 60 seconds with a perfusion flow of 1500 µL/min. The 
simulation also predicted that higher exchange rate  at the main loading channel than either 
outlet channel. Thus, the microperfusion pattern was in excellent agreement with the CFD 
simulation (Figure 4.6).  
 
Figure 4.6 Mass transfer across the simulation and experimental stages of the microfluidic device is 
demonstrated. The device is perfused with 0.04% Trypan blue dye at a volumetric flow of 1500 
µL/min. The perfusion time is recorded at 0s, 20s, 40s and 60s. Colour indicates the exchange flow 
rate concentration inside the device. 
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The microfluidic system was designed to the one-embryo-capture-sort concept (Figure 4.7), 
taking advantage of the gravitational-induced sedimentation of the embryos and low 
pressure force from a peristaltic pump working constantly at both outlet channels. Upon 
entering the device, the embryos rolled along the bottom surface of the channel under the 
influence of a drag force. The design enabled the sorter wheel to receive and immobilise an 
individual embryo using hydrodynamic forces. Only a single embryo was docked in the 
receptacle’s trap, and following docking the receptacle rotated 45° clockwise or 
anticlockwise towards an output channel, thus enabling positive and negative sorting, as 
shown in Figure 4.8. 
 
Figure 4.7. Overview of sorting principle (A) Illustration of embryos flowing towards sorting trap 
(width 1.6 mm, height 2 mm). Blue arrow represents water flow. B) Single embryo trapped in the 
sorting pocket. C) Sorter wheel rotated via servomotor to direct embryo into one of the outlet 
channels. D) Sorted single zebrafish embryo entering outlet channel. 
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Figure 4.8 Experimental validation of the sorting concept. A) Live embryo of 16 hpf stained with 
Trypan blue dye entering inlet channel. B) Embryo trapped and immobilised in a sorting pocket. C) 
Receptacle is rotated towards the outlet channel. (D) Recovery of embryo moving towards outlet 
channel. Scale bar size denotes 800 µm.  
4.4 Discrimination of live from dead embryos using differential infrared 
optical density (DIOD)  
Transparent objects such as Live embryos absorb light at a certain wavelength [259]. This 
absorption is measurable in the intensity response. We used a standard infrared (IR) emitter 
and receivers. With this, one of the embryo detection concepts was to use the electronic 
sensor detection module enabling oscilloscopic identification of DIOD by employing IR 
emitters and receivers, embossed within the chip. This straightforward detection method 
exploited optical characteristics of embryos: the IR sensors used a light sensor like LED to 
detect a specific light wavelength in the IR spectrum. When a dark or solid object passed 
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through the sensor, less light was received by the sensors. This difference in the light 
received was measured by a voltage threshold as shown in Figure 4.9. 
The live specimens were optically transparent, while dead embryos were opaque due to the 
release of proteolytic enzymes during tissue necrosis, which led to a pronounced 
coagulation of embryo tissues. To enable detection of live vs dead specimens based on 
DIOD, an IR emitter and detector were embossed in opposite walls of the microfluidic 
channel. The embryos was introduced by passive pumping automatically, moving past in a 
single line, were exposed to the IR beam and a digital storage oscilloscope detected and 
recorded the characteristics of the light by measuring voltage output from the IR detector 
(Figure 4.9). The average output signals from the oscilloscope were calculated as, 
        , where V1 is the voltage source and V2 is the voltage threshold. The latter 
could then be programmed to trigger the actuation of the revolving receptacle that 
mechanically redirected live and dead embryos into separate streams.  
 
Figure 4.9 Experimental validation of live and dead embryos with embryos flowing in as in a single 
file at a perfusion rate of 1500 µL/min. Red dotted image depicts the measurement of average 
voltage, ΔV of the obtained signals over time. Oscilloscope waveform of diverse mixtures of live and 
dead embryos with values of 29 mV and 1 V.  
To establish baseline voltage values, live and dead embryos (n=100) were initially flown 
through the microfluidic IR detection module at a constant flow rate of 1500 µL/min. We 
were successfully able to discriminate live and dead embryos by their DIOD values alone, 
with average voltage values of ≤ 100 mV and ≥ 500 mV established for live and dead  
embryos, respectively. To perform a preliminary performance validation of the DIOD 
detection concept, live and dead embryos were mixed in different ratios: i) 100% live 
embryos, ii) 90% live embryos, iii) 50% live embryos, iv) 1% live embryos, and v) 100% dead 
embryos. These were flowed through the microfluidic IR detection module at a constant 
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rate of 1500 µL/min. During those experiments the AM7013MT Dino-Lite Premier 
microscope was positioned above the IR sensing module to validate accuracy of 
oscilloscopic identification of differential infrared optical density. 
The results indicated that DIOD sensing was able to achieve 90–100% detection efficiency 
for live embryos and 60–87% for dead embryos, as illustrated in Figure 4.10 A. Fewer than 
26% of embryos were aborted and more than 50% purity of the detected dead embryos was 
achieved during the detection process, as shown in Figure 4.10 B . Although the results of 
the DIOD sensing method are promising, they were affected by significant voltage 
variability, mostly due to lack of signal amplification and signal-to-noise issues. 
 
Figure 4.10 Experimental validation of IR sensing (A–B) of live and dead embryos with embryos 
flowing in in single file at a rate of 1500 µL/min. Detection efficiency and detection purity of dead 
embryos in diverse mixtures of live and dead specimens were calculated. Detection of dead embryos 
using robotic vision software  
To eliminate problems associated with DIOD sensing method, we explored the potential of 
robotic vision software algorithms that could detect and track in real time a population of 
embryos moving in a single file inside a microfluidic channel. A customised algorithm was 
created in RoboRealm software to enable detection and tracking of dead embryos, based on 
their black colour intensity. During those experiments, the AM7013MT Dino-Lite Premier 
microscope was positioned above the microfluidic channel and set to an optical 
magnification of 45X. This corresponded to a field of view of 60 mm2 that was deemed 
sufficient to identify embryos rolling on the surface of the chip-based device. The video 
stream, at 30 frames per second, was fed via a USB2.0 interface to a PC running RoboRealm 
software; see Figure 4.11 A. 
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Figure 4.11 Robotic image acquisition of Roborealm software for sorting. (A) Real-time video 
acquisition and detection of dead embryos at a flow of 2500 µL/min. The blue circle indicates 
detection of the dead embryo when the software recognises it. The designed algorithm specifically 
used a colour module for tracking the dead embryos (RGB_Filter Gray –> Smooth Hull –> Blob 
Tracking –> Blob Replace). The blue arrow represents the direction of the fluid flow inside the 
microchannel. (B) Tracking efficiency of dead embryos rolled inside the microchannel at low to high 
volumetric flow rates. 
 
Figure 4.12 Vision recognition using image intensity for both coagulated (left image) and viable (12 
hpf) (right image) embryos. The algorithm was modified to distinguish both types of embryo when 
the sensing detection process started. (Canny 0-4 -> Smooth Hull -> Circles -> Display Circle -> Write 
AVI). Average mean intensity values of ≥ 126 (live embryo) and ≤100 (dead embryo) were achieved  
The red boxes show the mean intensity value that the captured image required. Bar scale is 250 µm. 
A pilot study was carried out to determine the accuracy and repeatability of the image 
tracking system. The results shown in Figure 4.11 B indicate that the robotic vision sensing 
method can achieve 100% detection efficiency when a pure population of dead embryos is 
loaded on a chip-based device. The embryos were successfully tracked and detected while 
flowing at a high rate in the microfluidic channel. This showed that the robotic vision 
software was capable of achieving a high accuracy of detection. However, the programmed 
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algorithm was capable of detecting only the coagulated embryos, due to the transparency 
characteristics of the live embryos. 
The image of the embryos later were captured in a static condition for image processing. 
The algorithm was modified to meet the requirements of detecting translucent specimens 
such as live embryos. It masked the background of the image concentrating on the area of 
the embryos. With this modification, mean intensities of the image were captured and 
measured (Figure 4.12), and live and dead embryos were distinguishable with the calculated 
intensities.  
 
 
Figure 4.13 Experimental validation of real time video detection using RoboRealm software (A–B) of 
live and dead embryos with embryos flowing in in single file at a rate of 1500 µL/min. Detection 
efficiency and detection purity of dead embryos in diverse mixtures of live and dead specimens were 
determined. The results suggest that robotic vision detection is more accurate than DIOD sensing. 
The image processing algorithm was able to differentiate between live and dead embryos flowing 
through a microfluidic device. In addition, the method reduced tracking inaccuracies and increased 
the detection sensitivity of the specimens that were distinguished.  
Further exploration was undertaken to detect both living and dead embryos when they 
appeared in different proportions. The preliminary performance was validated by mixing 
embryos at different ratios i) 1% live and 99% dead; ii) 50% live and 50% dead; iii) 90% live 
and 10% dead. These were run at a flow of 1500 µL/min. In almost all instances the real-
time video tracking algorithm achieves more than 96% and 82% detection efficiency of live 
and dead embryos respectively ( 
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Figure 4.13 A). Fewer than 18% of embryos were aborted and 100% detection purity of dead 
embryos was achieved during the real-time video detection if the proportion of live 
embryos was more than 50% ( 
Figure 4.13 B).  
4.5 Summary and conclusions  
The application of LOC technologies for in situ manipulation and handling of small model 
organisms such as zebrafish embryos has attracted a great amount of interest in various 
fields and particularly in biomedicine. The use of microfluidic chip-based devices for this 
application is limited because of the constraints imposed in fabricating a device on a 
millilitre scale, and because of biocompatibility issues, and manual procedures are time 
consuming and prone to errors, limiting research efficiency. There have been some 
achievements in developing cytometrics for large particle analysis and robotic automation 
sorting systems, but these are complex and users must be trained in their use [54]. Simpler 
detection methods and procedures are needed to improve the operation of sorting 
embryos. 
A proof-of-concept design for a micromechanical large particle in-flow sorter, capable of 
analysing, sorting and dispensing live vs. dead zebrafish embryos, has been demonstrated. 
The core design features an embedded revolving micromechanical receptacle actuated in a 
non-contact mode using a robotic servomotor. The microfluidic sorter was developed to 
distinguish between live and dead embryos. A sensing method linked with image processing 
was found more efficient than wavelength sensing methods such as IR sensors. The 
programmable machine vision system is capable of detecting embryos whether they are 
moving or in stasis. 
This work demonstrates a new concept for sorting and handling zebrafish embryos in 
miniaturised chip-based devices. A simple and compact microfluidic device was fabricated to 
overcome current problems of size associated with available sorting systems. This newly 
developed design offers a new paradigm for miniaturised and automated sorting devices 
capable of handling large particles such as embryos and small model organisms.  
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However, this study focused only on the development of the conceptual design, its 
fabrication, and the testing of various detection methods to distinguish between two types 
of embryo. This was due to limitations in integrating the software with the motion system 
(servomotor). A continuous feedback system in the form of accurately positioned set points 
is required in an accurate sorting mechanism. The RoboRealm software often crashed when 
the servo control was turned on, resulting in the system being unable to decode the embryo 
images. Upcoming work will concentrate on the development of a fully integrated sorting 
system combined with automated loading, real-time sorting decision-making algorithms and 
automatic dispensing of embryos for further pharmacological testing.  
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5  Millifluidic Device for Immobilisation of 
Zebrafish Larvae for Cardiotoxicity Analysis 
5.1 Introduction  
Most commonly used methods to fabricate millifluidic devices for large model organisms 
utilise either direct infrared laser ablation in PMMA or laser micro-machining of PMMA 
moulds combined with replica moulding in poly(dimethylsiloxane) (PDMS, Sylgard 184) 
elastomer [27]. Most recently, additive manufacturing methods such as stereolithography 
(SLA) have been shown as one viable alternative for the fabrication of optically transparent 
microfluidic as well as millifluidic devices. [166].  
This chapter describes the capability of high-definition 3D printing in additive manufacturing 
systems to fabricate optical-grade transparent moulds suitable for replica moulding for 
millifluidic chip-based devices. As mentioned in Chapter 1, using standard photolithography 
processes to creates prototypes of millimetre scale, high-aspect ratio devices required for 
large metazoan organisms is difficult and time consuming. The main objective of this project 
was to investigate the feasibility of using 3D printing for the direct, one-step creation of 
non-planar PDMS chip-based microfluidic devices with higher dimension accuracy and 
surface quality than is currently achieved. A design for a direct PMMA mould was selected 
as the control for comparison with other fabrication techniques; this was then fabricated 
using three different 3D printers and three different printing materials. The reproduction 
quality of such features as geometric accuracy of the printed moulds was assessed. 
Prototypes were evaluated using SEM and quantitative 3D topographic surface mapping 
using optical profilometry. The x-y and z resolution of the printed moulds were also 
evaluated and compared. 
Here we demonstrate the design and development of PDMS millifluidic devices for trapping 
and immobilising living zebrafish larvae. The developed devices were used for the 
physiological cardiac rate assessment of the larvae under the continuous influence of drugs 
or chemicals. 
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5.2 Millifluidic chip design and fabrication  
The millifluidic chip was fabricated using a combination of 3D-printed negative relief moulds 
and soft lithography. The initial CAD design for the mould, shown in  
Figure 5.1, enabled automated docking and immobilisation of living zebrafish larvae in a 
linear array of ten traps (0.8 mm x 0.8 mm x 3.5 mm) with curvilinear corners (r = 1.5 mm) ( 
Figure 5.1). This feature ensured smooth movement of the larvae during docking and 
avoided specimen damage. The design utilised a hydrodynamic trap principle with a passive 
hydrodynamic flow for larvae docking and immobilisation, as described in Chapter 4 (4.3) 
[27]. Control devices were fabricated using conventional techniques as described in Chapter 
3 (3.7) [166].  
The suction channel was positioned at the top of each trap channel that is connected to an 
outlet channel.  A thrust channel (0.7 mm x 0.8 mm x 0.8 mm) was located vertically at the 
opposite of the entrance to each trap, to increase the hydrodynamic flow of that trap.The 
inlet and outlet connection ports, with diameters of 3.0 mm, were used for direct tubing (Ø 
internal diameter= 1.3 mm).  
 
Figure 5.1 Overview of CAD design of the negative relief mould for larvae immobilisation millifluidic 
chip. A detailed view of section A is depicted on the (right).  
The overall internal volume of the device was approximately 230.2 µl, while the volume for 
a single trap was 2.29 µl. A control comprising devices fabricated by conventional 
techniques, such as soft lithography in PDMS and infrared laser computer numerical control 
(CNC) micromachining in PMMA, was described in Chapter 3 (3.7) [166].  
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The relief mould was then printed on VisiJet SL Clear (VJC), Vero Clear (VC) and Form Clear 
(FC) materials. None of the printed moulds required additional bonding procedures, but the 
relief mould fabricated from PMMA materials needed thermal bonding; it was selected as 
the control for this study. The final surface finish of all printed moulds and final microfluidic 
device were comparable with the control, except that the mould was tinted and not fully 
transparent (Figure 5.2). All moulds were further used to fabricate elastomeric PDMS 
structures using soft lithography as illustrated in Figure 5.3 and Figure 5.4. The inlet and 
outlet connection ports (Ø = 3.0 mm) were manually punched holes; both PDMS structures 
were cleaned and bonded using oxygen plasma cleaner equipment. 
 
Figure 5.2 An illustration of showing zebrafish larvae trapping arrays using different additive 
manufacturing methods. CO2 laser micromachining used to cut the thermoplastic material of 
polymethylmethacrylate (PMMA) and designated as the control. The 3D printed moulds were 
fabricated using stereolithography (SLA; in VisiJet SL Clear and Form Clear resins) and multi-jet 
modelling (MJM; in Vero Clear resin).  
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Figure 5.3 A PDMS chip-based device to trap 3dpf zebrafish larvae. The main body was fabricated of 
polydimethylsiloxane (PDMS) with a PMMA mould, bonded to a standard microscope slide (sealing 
layer). This is referred to later as PMMA-PDMS for the control fabrication. 
 
 
Figure 5.4 A photograph of 3D printed mould and the final fabricated PDMS chip-based device. All 
PDMS structures were comparable with the control (PMMA-PDMS) in shape and transparency. The 
soft lithography process does not affect the appearance of the final microfluidic devices. 
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5.3 Characterisation of 3D-printed moulds for soft lithography  
The reproductive quality of additive manufacturing for both SLA and MJM systems was 
investigated using the smallest features of the prototype, such as the suction channels and 
other trapping regions, as shown in Figure 5.5. Prototypes were evaluated on their critical 
key features: aspects of 3D printed LOC devices such as geometric representation 
accuracies, material structure and optical transparency using scanning electron microscopy 
examination, and quantitative 3D topographic surface mapping using optical profilometry. 
The x-y and z resolution of additive fabrication compared favourably with other forms of 
rapid manufacturing such as direct infrared laser ablation in PMMA and laser micro-
machining of PMMA moulds combined with replica moulding in poly(dimethylsiloxane) 
(PDMS, Sylgard 184) elastomer. [27] The latter process will here be referred to as PMMA-
PDMS and is the control fabrication. All 3D printed moulds and PDMS structures were 
characterised in detail to determine their geometric accuracies and surface morphology.  
5.3.1 Geometric accuracies  
Surface characteristics of geometric patterns differing from the theoretical (designed) 
dimensions depended on the process of additive manufacturing used in 3D printers. 
Nominal dimensions were designed in CAD; three different widths, illustrated in Figure 5.5, 
were selected for geometrical measurement. The accuracy of the printing was evaluated by 
comparing the selected dimension with the actual dimension of the smallest features of the 
prototypes, 300 µm (Figure 5.6). Both moulds and PDMS were measured accordingly and 
some variations in the dimensions were found. SLA fabrication methods produced 20% 
fewer deviations than the others. In practice, the dimension of the PDMS structure is larger 
than in theory, a result of the moulding and demoulding process. 
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Figure 5.5 Geometrical representation of a single trap. Suction width (A), trap width (B) and entrance 
width (C) were measured after the 3D printing fabrication. Actual CAD dimensions (in mm) were 
compared with actual 3D printed mould and PDMS.  
 
Figure 5.6 Comparison of measured deviations of the trap structures for all fabricated 3D printed 
moulds. The theoretical width of suction is designed in CAD is to be 300 µm. All printed moulds were 
comparatively accurate except for Form Clear. Apart from the PDMS structure made from the 
PMMA mould, all other additive manufacturing methods were relatively precise.  
5.3.2 Surface topography  
Surface topography, such as the surface roughness of the fabricated structures of the 3D 
printed moulds, is important as poor surface quality will affect the performance of the 
device. Higher surface roughness on the 3D printed mould surface affects the outcome of 
the fabricated relief negative PDMS. Moreover, a rough surface will encourage a turbulent 
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rather than a laminar flow in the system. A detailed assessment of the surface topography 
was made of all 3D printed materials. To obtain a good conductivity and sensitivity of the 
scanned surface, all printed moulds were coated with gold in prior of imaging.  
 Scanning Electron Microscopy  
The surface topography of the 3D printed moulds and PDMS were first analysed using a 
scanning electron microscope for visual comparison with the control PMMA mould surfaces. 
The VJC mould showed smooth top and bottom surfaces, while the VC showed an uneven 
‘wavy’ texture: a direct thermal effect of instant UV curing after the resin layers were 
injected on the surface. By comparison, the Form Clear showed roughness on all printed 
surfaces, as illustrated in Figure 5.7. On the bottom surface of the FC moulds, porous 
structures were noticeable, which caused damage to the PDMS structure during soft 
lithography.  
 
Figure 5.7. Topographic surfaces of 3D printed moulds of the larvae traps are depicted using SEM. 
The VisiJet Clear was observed to have a smooth surface comparable with the conventional PMMA 
mould. SEM image for VJC presented more uniformity of the layer resolution of 800 µm (thickness) 
than the other additive manufacturing methods. 
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Next, the view was magnified and focused on the top surface of the printed 3D structures 
(Figure 5.8). Debris caused by removing material by laser ablation had accumulated on the 
top PMMA surface, as it could not escape from the cutting zone while being machined. 
There was also evidence of incomplete deposition of the resin on the FC mould. Some resin 
materials were not polymerised and thus collapsed at the centre of the structure, producing 
a large, deep indentation.  
 
Figure 5.8 Comparison of topographic surfaces using SEM, depicting the top surfaces of the larvae 
trap. All the 3D printed moulds achieved a smooth top surface finish apart from the Form Clear 
mould, which suffered from incomplete layering of the resin while printing. 
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Figure 5.9 Comparison of topographic surfaces using SEM, showing a close view of the suction 
channel on all 3D printed moulds. Only VisiClear showed good layer deposition. 
Each suction channel was magnified to observe the vertical walls; the deposition layer of the 
resins in all 3D printed moulds were also depicted. VJC and VC had uniform sidewalls and FC 
showed deformed structures. Although the desired thickness is achievable in PMMA, laser 
technology failed to cut the materials with a dimension of less than 300 µm. The damage to 
the  surface was an effect of the laser, which produced a small heat-affected zone at the 
end of the process (Figure 5.9). 
 Optical profilometry  
To evaluate the surface analysis, 3D surface mapping of optical profilometry was used. An 
area of 500 µm x 500 µm was scanned by the laser beam at both top and bottom surfaces. A 
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surface mapping contour was presented as the outcome. The red area represented the peak 
while the blue areas indicated valleys. The green zone was set as the reference panel. The 
the heights on the surface were presented as a Gaussian distribution, and so a surface 
roughness was obtained for each scanned surface.  
The surface profiles of both PDMS and printed mould surfaces were analysed. Importantly, 
when prototypes were examined using optical microscopy, significant differences in surface 
roughness were readily observed in the different resins used in manufacturing. A 
significance difference in average roughness, Ra for the top (mould) of PMMA, VJC and FC, 
were readily observed in the different resins utilised for manufacturing. Overall, traps and 
channel microstructures embedded within the chip were consistently fabricated with the 
highest accuracy, in VJC with Ra =18 µm (Figure 5.11) compared with PMMA (Figure 5.10). 
They reflected the outcome of different post-treatment processes to remove support 
materials. 
 
Figure 5.10 Surface topographic analysis of 500 µm x 500 µm area size of top surface of mould 
structures (left image). The Gaussian distribution on the surface texture is represented by the 
median height (right image). A smooth surface has a median height of 92 µm and width of 86 µm.  
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Figure 5.11 Quantitative analysis of surface topography of an area of 25 mm2 the top of VisiJet SL 
clear printed moulds (left image). The Gaussian distribution was symmetrical on the surface texture 
(median height) (right image). The surface was smooth and relatively flat compared to the control 
(PMMA) as is indicated by the small variations in the distribution curve.  
 
Figure 5.12 Surface profilometry analysis of the selected scanned area (500 µm x 500 µm) (left 
image). The skewed Gaussian distribution on the surface roughness (median height) is presented 
(right image). Large variation in the histogram distribution with relatively rough texture is observed 
as the peaks are greater than the valleys with Ra value of 28 µm for FC mold. 
In contrast to PMMA and VJC moulds, the FC surface showed a random view of the peaks 
and valleys. Although the variation was equally distributed, void spaces clearly observed in 
areas of the map resulted in rough surface texture (Figure 5.12). This is due to incomplete 
polymerisation during printing and post-processing of the support resin. The irregularities in 
the texture promoted adhesion during the soft lithography process, which damaged the 
PDMS. This indicated that FC was not suitable for printing structures less than 300 µm in 
dimension.  
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5.4 Device performance for zebrafish larvae trapping  
5.4.1 The concept of larvae trapping and immobilisation  
The millifluidic system was designed for automatically trapping and positioning larvae, 
based on the gravity-induced sedimentation of the larvae and the low-pressure suction at 
the top of the traps. Low pressure from a peristaltic pump was applied at the outlet of the 
chip, and larvae were then with head facing forward, one at a time at a set interval, from a 
reservoir into the inlet channel. Upon entering the device, the anesthetised 3dpf zebrafish 
larvae with heads facing forward flowed along the microchannel under influence of a drag 
force. This design allowed some individual zebrafish larvae to be trapped and immobilised 
by the hydrodynamic forces. The trapped zebrafish increased the flow resistance. 
redirecting the main stream flow to the other channels. The following larvae bypassed the 
occupied trapping channel and were directed into the next trap. After the larvae were 
trapped, they remained immobilised and a flow rate of 1000 µl/min was continuously 
perfused to maintain positive pressure throughout the system, as shown in Figure 5.13. 
 
Figure 5.13. Overview of larvae trapping principle: (A) Illustration of zebrafish larvae flowing towards 
entering the trap (0.8 mm (width) x 4.0 mm (height) x 0.8 mm (thick)). Blue arrow represents water 
flow (rate = 2000 µl/min) (B) Single zebrafish larvae immobilised inside one of the traps (C) 
Subsequent zebrafish larvae flowing towards next trap (D) Zebrafish larvae immobilised inside the 
trap and acclimated for fine minutes with a constant flow of 1000 µl/min. 
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5.4.2 CFD simulations 
CFD simulations were initially performed (COMSOL Multiphysics v4.4) to predict flow 
velocity, pressure drop and uniformity of mass transfer inside the device (Figure 5.14). The 
simulation indicated that at a flow rate of 1000 µl/min, velocities inside the chip varied from 
0.0026 m/s to 0.013 m/s, at input and output respectively. The trap had a constant velocity 
of 0.02 m/s with a constant flow pressure of 28 Pa, and the thrust channel (velocity = 0.036 
m/s) and suction channel (velocity = 0.06 m/s) were able to immobilise the zebrafish larvae.  
 
Figure 5.14 CFD simulation of the theoretical prediction of fluid flow inside the millifluidic chip with 
an inlet flow of 1000 µl/min  
The functional characteristics of additively manufactured prototypes were investigated next. 
The design of the chip allowed automatic trapping of individual larvae using hydrodynamic 
forces. Upon entering the device, the anesthetised zebrafish encountered a drag force that 
guided them to a trapping region. Every trapped zebrafish larva increased the flow 
resistance and redirected the streamline to subsequent traps. After the larvae were trapped, 
they could remain immobilised for up to 24 hours. Trapping efficiency was calculated as the 
number of captured larvae divided by the number of larvae injected into the device (Figure 
5.15). The results indicate that efficiency was greatly affected by feature reproduction and 
surface topology caused by different techniques of additive manufacturing. Fewer than six 
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larvae could be trapped in an array consisting of 10 traps, in all fabricated PDMS chip-based 
devices.  
 
Figure 5.15 Comparison of trapping performance of zebrafish larvae between devices fabricated 
using different techniques. The volumetric perfusion rate range tested from low to high volumetric 
flow rate. 
5.5 Improving the design  
Amendments were made to the design of the PDMS chip-based design. Given the low 
trapping efficiency of the earlier design, the number of traps was reduced to achieve higher 
efficiency. Five traps in a linear array were placed in an area similar to that of a standard 
microscope slide. Additional mirrored arrays were placed to act as replicates of the opposite 
array (Figure 5.16 A). 
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Figure 5.16 Overview of modified design of the negative relief mould. (A) A detail of the CAD design. 
A linear array of five traps was designed (green image). Each individual trap has the same 
dimensions as in the previous design. (B) Realistic image of the printed mould. Inlet and outlet ports 
(Ø = 2.7 mm) were 3D printed directly (red dotted image). This eliminated the hole punching process 
for direct tubing.  
A new CFD simulation was run to envisage fluid flow inside the microchannels (Figure 5.17 
A). The inlet and outlet velocities were 0.014 m/s and 0.0055 m/s respectively. A wider 
thrust channel (0.80 mm) was located opposite the entrance to the trap, providing a 
hydrodynamic force that increased the velocity (0.0078 m/s), focusing on the single trap. 
The overall internal volume of the device was approximately 189 µl while the volume for a 
single trap was 2.29 µl. 
Mass transfer experiments with 0.04% Trypan blue dye (Life Technologies Corp, CA, USA) 
visually demonstrated the flow of fluid inside the microfluidic chip (Figure 5.17 B-G). The 
mass transfer experiment was conducted to predict the perfusion time of the toxicant or 
chemicals, from entering the inlet and moving to all traps and finally to the outlet channel. A 
100% drug delivery across the whole device took less than a minute at a flow rate of 1000 
µL/min. Next, negative relief moulds were printed, using VC materials for all millifluidic 
devices because of the good surface integrity and performance it demonstrated earlier in 
Chapter 5 (5.2). 
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Figure 5.17 CFD of the microfluidic device for trapping 3 dpf zebrafish larvae. (A) Predicted velocity 
streamline of the entire array of the device. The simulation of mass transfer flow (B–D) and 
experimental fluid flow using 0.01% Trypan blue dye (E–G). Time taken was 0, 30 and 60 seconds. 
Volumetric perfusion rate used was 1000 µL/min.  
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The hydrodynamic force of the fluid led the moving larvae inside the loading channel. The 
thrust channel increased flow towards the trap and guided the larvae inside. The 
microfluidic array used the concept of a single-larvae-trap allowed only one larva per trap at 
any time. The larvae did not trap in sequential order because they were partially 
anesthetised; twitching larvae moved to the next trap. Eventually, 100% trapping efficiency 
was achieved with this modified design (Figure 5.18). 
 
Figure 5.18 The complete loading of the larvae inside the traps took approximately five minutes 
depending on the larvae flow gap and flow rate selected. All 3 dpf larvae were anesthetised with 100 
mg/L Tricaine before loading. Flow rate for trapping the larvae was 1500 mg/L. 
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5.6 Biocompatible chip-based physiometer 
5.6.1 Influence of Tricaine (MS-222) on zebrafish heartbeat  
Zebrafish larvae can be immobilised by applying anaesthetic drugs such as Tricaine that 
inhibit muscle contraction by suppressed the nerve membrane. This has an effect similar to 
other anaesthetic drugs [260]. A range of Tricaine concentrations from the low dose of 0.01 
mg/ml to 0.8 mg/ml have been used as sedatives for zebrafish larvae [261, 262]. Tricaine 
suppresses contractions in smooth and cardiac muscles, and reduces the heart rate 
significantly at doses greater than 0.17 mg/ml [263]. The Tricaine concentrations selected 
were as low as possible: up to 0.20 mg/ml for cardiac analysis. In this work, the heart rate of 
the 3 dpf larvae were examined at selected doses of 0.02 mg/ml – 0.18 mg/ml Figure 5.19 
A–B. A reduction in heart rate was found to be higher (15%–45%) than in the control group 
when the Tricaine concentration increased at time = 0 hr; but a substantial reduction was 
observed after 24 hours of exposure at a value of 44%–66% from the control. 
 
Figure 5.19 Dose concentration effect of Tricaine on 3 dpf zebrafish larvae at concentrations of 0.02–
0.18 mg/ml: (A) at immediate time after being exposed with the Tricaine; (B) heartbeat of zebrafish 
larvae at time=24 hr. Results are represented as the mean ± standard deviation (SD), n=20.  
Conventionally, mounting media such as agarose have been used for various microscopic 
imaging purposes as their refractive indexes are comparable with water [264]. The effect of 
the mounting medium on the zebrafish heartbeat was studied in 0.5–1.5% agarose. Heart 
rates of 3 dpf larvae were found to be significantly increased at 1.5% of agarosecompared 
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with the larvae inside the petri dishes. This is due to a hypoxic response in the larvae, 
compared to those freely swimming [265]. Zebrafish suffer environmental stress when 
placed in higher concentrations of mounting media, as seen in Figure 5.20. The same effect 
was observed when the larvae were trapped inside the microfluidic chip in Figure 5.21, due 
to the release of stress hormones such as adrenaline in preparation for an escape response. 
[266]. This behavioural response in zebrafish does not lead to mortality and stress, so such 
microfluidic devices can be used as toxicity assays.  
 
Figure 5.20. Agarose mounting (0.5–1.5%) effect on 3 dpf zebrafish heartbeat. The asterisks denote 
significant differences from the control group (*p<0.05 and **p<0.01). Results are represented as 
mean ± standard deviation (SD). (n=20, 3 replicates).  
 
Figure 5.21. Effect on 3 dpf zebrafish heartbeat in different environmental conditions. The asterisks 
denote significant differences from the control group (*p<0.05 and **p<0.01). Results are 
represented as mean ± standard deviation (SD), n=20. 
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5.7 Effect of toxicity on zebrafish heartbeat  
Acute toxicity biotests were performed using selected cardio-active compounds: caffeine, 
nicotine, verapamil hydrochloride and lead acetate. The compound toxicity profiles were 
evaluated using a standard bioassays protocol according to OECD guidelines for the testing 
of chemicals. In the toxicity tests, 3 dpf zebrafish larvae were used. A 10% lethal 
concentration (LC10) was used; each lethality curve was determined and plotted using the 
probit analysis ToxRat software. According to the corresponding concentration–response 
curve illustrated in Figure 5.22, LC10 was 195 mg/L for caffeine, 162 mg/L for nicotine, 102.58 
mg/L for verapamil hydrochloride and 32.88 mg/L for lead acetate. The same concentrations 
of LC10 were used as solvents for cardiovascular assessment (heartbeat measurement) of 
the larvae in the microfluidic arrays.  
 
Figure 5.22 Dose-dependent mortality tests: selected toxicants’ effects on 3 dpf zebrafish larvae. The 
curves represent the response for each of the selected cardio-active compunds. The values of LC10 
were calculated by probit analysis using ToxRat software. Experiments were carried out in triplicate; 
in each n=20 larvae were pooled for calculation of the concentration. Lead acetate was found to be 
toxic at low concentrations compared to the others. 
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5.8 Drugs treatment modulates heartbeat using microfluidic device  
5.8.1 Short-term infusion of drugs  
This study validated the applicability of the newly designed PDMS chip-based devices for 
real-time monitoring of heart rate variations in zebrafish larvae. It also investigated the 
effects of sublethal concentrations of various compounds (LC10) on the heart rate of 
zebrafish. For this purpose, the anesthetised 3 dpf larvae were loaded into the devices and 
perfused with LC10 of caffeine, nicotine, verapamil hydrochloride and lead acetate (Figure 
5.23). The selected compound did not affect the zebrafish heart development. Monitoring 
of the heart rate variations was performed via non-invasive video microscopy. 
 
Figure 5.23 Zebrafish larvae (3 dpf) immobilised on the microfluidic device. Heart rates were 
recorded for one minute with USB microscope (Dino-Lite) at 60 frames per second. The videoed 
records of cardiac activity were analysed using DanioScope software. The heart area was selected for 
analysis.  
Caffeine is a widely consumed stimulant of the central nervous system (CNS). A high intake 
of caffeinated drinks increases the risk of cardiovascular disease [267]. It was observed that 
the heart rate increased significantly to over 150 beats per min (bpm) when larvae were 
exposed to 195 mg/L of caffeine (Figure 5.24 A). This was due to its antagonistic effect on 
adenosine receptors, that increased the muscle contraction of the heart. The same trend 
has been observed in previous reports showing that caffeine has strong effects on the 
cardiovascular system and blood vessels [268, 269].  
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Figure 5.24 Detection of heart rate difference in 3 dpf zebrafish larvae after ten minutes perfused 
with drugs that decrease and increase heart rate. Cardiac rate increased after the administration of 
caffeine (A) and lead acetate (D). In contrast, nicotine (B) and verapamil hydrochloride (C) induced a 
decrease in heartbeat. Each treatment was compared with a vehicle control 0.05% of dimethyl 
sulphoxide (DMSO). All values represent the mean ±SD (**p<0.01)(n=20). 
 
Nicotine, one of the alkaloids found in tobacco, is highly addictive. Tobacco is mainly used in 
cigarettes; it induces many diseases that affect the heart and liver as well as causing cancers 
[270]. Previous reports have shown that all components inside cigarette smoke, including 
nicotine, can infuse into the human placenta and influence foetal development [271]. In this 
study, sublethal concentrations of LC10 were infused into the microfluidic system. They were 
followed by a significant reduction of 34% in the embryos’ heartbeat compared with the 
control group, as shown in Figure 5.24 B. This reduced heart rate indicates that nicotine is a 
possible cause of cardiac failure [272, 273]. 
Verapamil is a antihypertensive drug that acts as a calcium channel blocker and is used in 
the treatment of hypertension, supraventricular arrhythmias and angina pectoris [274]. 
Short-term exposure to verapamil in these tests showed a decrease in cardiac contractions 
of 20% compared to the control (Figure 5.24C). This result is consistent with earlier reports 
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that have shown that verapamil causes bradycardia and atrial ventricle block in zebrafish 
[244]. The calcium blocker agent reduced myocardial contractility, heart rate and impulse 
conduction of the heart; it helped to calm the blood vessels and thereby reduced the 
workload on the heart [275].  
Lead (Pb) has the potential to affect human health. It induces a broad range of 
dysfunctionalities, biochemical, physiological, and neurological, in humans [276]. In this test, 
the zebrafish experienced the same effect after being exposed to lead acetate concentration 
of 32.88 mg/L as shown in Figure 5.24 D. The heart contractions were found to be 
statistically significantly higher, by 7%, than the control treatment. This indicates an 
adaptive response by the zebrafish larvae to exposure to heavy metal concentrations [277].  
5.8.2 Short term infusion–elimination–reinfusion of drugs 
Next, the capability of the microfluidic chip for determining heart contractions per period 
was tested. An advantage of working with immobilised zebrafish larvae in the device is that 
the effect on the heartbeat of administering and withdrawing drugs can be analysed. 
Another advantage is that the observation of the positioned larvae can be done as a single 
process without the need of additional preparation to change the test concentration. This 
approach is more convenient and permits a high throughput. 
The results indicate that the heart rate increased significantly after seven minutes of 
caffeine treatment at a concentration of 195 mg/L, steadily reaching ten minutes of infusion 
at 170 bpm (Figure 5.25 A). During the elimination period, it was observed that the 
heartbeat slowly recovered to almost 149 bpm, close to the initial rate, before infusion took 
place. The same trend occurred on re-infusion of the caffeine after ten minutes. 
The overall effect of continuous nicotine administration decreases the heartbeat. The beats 
significantly decreased after six minutes from 152 bpm to 97 bpm, until the end of ten 
minutes of infusion. The heart beat then rose sharply during the elimination period, to 
between 11 and 13 minutes, and gradually reduced to 147 bpm. It was observed during re-
infusion that the heartbeat reading was more stable than at the initial administration of 
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nicotine. This shows that the response of nicotine is more effective than during 10 minutes 
initial infusion. 
 
 
Figure 5.25 Effect of cardioactive compound infusion on heart rate of 3 dpf zebrafish in the 
microfluidic chip. Fluctuations in bpm are measured as a function of time (minutes) during the 
infusion. Flow in the microfluidic was 1000 µl/min. Phase I – LC10 value for each compound was 
introduced into the microfluidic chip for ten minutes. Phase II – Infusion of Tricaine solution of 100 
mg/L for recovery and to remove the compound solution for ten minutes. Phase III – Re-introduced 
of the compound solution. Each heartbeat was compared to the baseline. Error bars represent 
standard deviations and n = 9 for each line. Data is presented by means of ± SD (**P<0.05). 
The effect of verapamil on the heart rate of zebrafish larvae can be seen in the infusion 
period, where a significantly reduced heart beat of 154 to 140 bpm and steady contractions 
were observed during the ten minutes of drug withdrawal. After this the heart rate 
gradually reached the initial baseline at recovery period. It was observed that in the 
reinfusion timeline, the effect of the drugs was slow compared with that of the initial 
administration. This is due to the effect of drug tolerance following re-infusion.  
In contrast, exposure to heavy metal, in this case lead acetate, produced a steadily higher 
heart rate within ten minutes of perfusion. In the elimination period, the heart experienced 
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a rapid recovery to below the baseline contractions at 144 bpm. The repeated intake of lead 
acetate was found to produce a more steady heartbeat compared than in the first 
administration. 
5.9 Summary and conclusions  
5.9.1 Design of the chip  
The use of additive manufacturing technologies for fabricating moulds with high aspect 
ratios of width to height (1:1-3) was explored. We successfully applied millifluidic 
technologies fabricated using SLA technology in a proof-of-concept manipulation of cardiac 
function in zebrafish larvae. A biocompatible chip-based physiometer for cardiac analysis, 
capable of trapping and immobilising zebrafish larvae, was also demonstrated. With this, 
heart rate variation in zebrafish larvae could be determined for cardiotoxicity studies. This is 
a novel method of monitoring the heartbeat of immobilised zebrafish larvae that can be 
applied to cardiotoxicity analysis in drug discovery. 
The newly developed microfluidic device is a new platform for cardiotoxicity assessment. 
The system is low cost, simple, non-invasive and operator independent. It allows more 
convenient heartbeat monitoring without the need of trained operators. Moreover, it only 
requires a single operation, with no need for additional procedures as in conventional 
methods of agarose mounting, in which zebrafish are transferred for new analysis.  
5.9.2 Effect of all drugs 
Compounds of selected drugs induced cardiovascular toxicity in zebrafish larvae. Caffeine 
and lead acetate showed heart rate-stimulating effects which increased the heart beat from 
the baseline by 16% and 9% respectively. In contrast, nicotine and verapamil stimulated an 
antagonist reaction to the heartbeat (Figure 5.26). All the drugs were observed have an 
effect on the heartbeat, although the concentration of Tricaine used did not affect 
heartbeat during infusion or elimination of the drug. By using the flow-through system for 
drug infusion, the consequences of taking drugs continuously can be seen. 
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Figure 5.26 The illustration of the heart rate response of 3 dpf in zebrafish larvae to cardioactive 
drugs. Overall, the caffeine exposure showed higher contractions of heartbeats compare to lead 
acetate. On the other hand, infusion of nicotine showed reduction increase heart rates than 
verapamil hydrochloride. Blue areas represent exposure of drugs of ten minutes duration (0-10 min) 
and re-exposure of drugs of ten minutes duration (20-30 min). Green area depicts the withdrawal 
and elimination of drugs (10-20 min). Note the baseline heart rates are comparable for all drugs 
tested. 
5.9.3 Limitations  
A possible limit of this method is the linear placement of larvae inside the device. The design 
placing the larvae have the effect of the larvae does not have the same amount of drug 
intakes. The variation in heartbeat could be reduced when every minute reading takes place. 
A linear array for trapping zebrafish larvae is not the most effective way to determine 
precise heartbeat readings.  
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6  Millifluidics for Dechorionated Zebrafish 
Embryos 
6.1 Introduction 
Zebrafish embryos are surrounded by chorion, a thin membrane of around 1.5–2.5 µm 
thickness, to protect the unhatched embryo at early development from 2 hpf (cleavage 
period: approximately 64 cell stage) to 24 hpf (pharyngula period: Prim-5 stage). The 
chorion potentially presents a barrier and protects its embryo from penetration by chemical 
substances. As reduced vulnerability to  the compound chemicals affects the results in acute 
toxicity studies, dechorionation (chorion removal) is used to investigate the sensitivity of 
chemical toxicities. 
In this chapter, we present a novel technology of lab-on-chip for automated embryo toxicity 
testing used in ecotoxicology and drug discovery applications. The biocompatible 
miniaturised LOC consists of arrays for loading, trapping and immobilising a single 
dechorionated embryo in a flow-through perfusion environment. The microfluidic chip-
based device was fabricated using soft lithography, as described in Chapter 3. The PDMS-
VisiClear chip-based device has optical-grade transparency, suitable for imaging the 
development of the dechorionated embryos. This system enables a continuous perfusion 
system of medium or toxicant exchange during embryo development. 
To validate the designed microfluidic system, dynamic computer simulations of the fluid 
flow were analysed and verified with experimental analysis. This proof-of-concept chip is a 
new platform for studies of morphology and of microfluidic toxicity testing (µFET) of 
dechorionated embryos. With this, we developed a novel and inexpensive technology in 
handling dechorionated embryos which offers great advantages in toxicity studies. 
6.2 Chip design and fabrication  
The proof-of-concept PDMS microfluidic chip consists of three main features: (i) the main 
channel for embryo loading and transport (inlet and outlet microchannels); (ii) the trap for 
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embryo docking and immobilisation; and (iii) suction channels that facilitate the 
hydrodynamic trapping of the embryos (Figure 6.1). All traps (T1–T20) were interconnected 
with the main embryo loading channel. Deflector channels (D1–D5) are positioned in each 
row of the linear array traps. 
 
Figure 6.1. The design of the negative relief mould for trapping dechorionated embryos. A total of 20 
embryo traps and each of the traps interconnected with cross-flow suction channels. Blue arrow 
represents the direction of fluid flow from inlet to outlet channel. ‘T’ indicates the number of 
consecutive traps and ‘D’ indicates the number of deflector channels. 
The CAD design for the mould as shown in Figure 6.2 enabled automated docking and 
immobilisation of 20 living 24 hpf dechorionated zebrafish embryos. The microfluidic device 
featured three integrated modules: (i) the curvilinear serpentine-shaped main channel with 
microchannels (width = 1.0 mm, height 0.7 mm) for embryo loading and medium perfusion 
as shown in Figure 6.2 A–B; (ii) a total of 20 embryo traps consisting of four individual traps 
at a distance of 1.52 mm (y-direction) in five rows with a hydrodynamic deflector to 
facilitate embryos towards other traps (Figure 6.2 C–D); and (iii) an array of suction channels 
(width = 0.2 mm, length = 0.87 mm , height = 0.7 mm) that connected the embryo traps 
with the main loading channel (Figure 6.2 E–F). The integrated modules of microchannels 
and traps allowed only single embryo docking through the well-shaped entrance, and 
smooth sliding towards the trap. The microfluidic design of the traps employed a passive 
hydrodynamic flow to dock and immobilise zebrafish embryos as described in Chapter 5 
(5.4) [27]. This feature avoided specimen damage and allowed development of the embryo 
inside the chip.  
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The overall internal volume of the device was approximately 288.7 µl and the volume of a 
single trap was 2.31 µl. The PDMS chip-based devices (illustrated in Figure 6.3) were 
fabricated using a combination of 3D-printed VisiClear negative relief mould and soft 
lithography, as described in Chapters 3 (3.9) and 5 (5.2). The negative relief mould  was 
fabricated with a top surface roughness of Ra= 11 µm. A biocompatible and optically 
transparent PDMS, similar in size to a standard microscope slide, was fabricated. Holes were 
punched vertically at the inlet and outlet ports to connect PTFE tubing to the microchannels 
for fluidic sample interfacing: for instance, a closed perfusion loop used a peristaltic pump 
linked to the tubing to provide a constant flow rate of 1000 µL/min for drug delivery.  
This proof-of-concept design has the advantage of being a one-step automatic 
hydrodynamic loading system for dechorionated zebrafish embryos. The design allows 
embryo docking and long-term immobilisation inside the traps. Significantly, the 
geometrical design of the traps assures only one embryo occupies a trap at a time, without 
obstructing other embryos’ passage towards the channels. The deflectors (D1–D4), on the 
other hand, were designed to enhance trapping efficiency by changing the trajectory of the 
embryos and pushing them towards the traps. 
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Figure 6.2. Detailed CAD design of the negative relief PDMS–VisiClear mould of the microfluidic 
device for automatic trapping and immobilisation of 24 hpf dechorionated zebrafish embryos. (A–B): 
Detailed design showing the dimension of the overall mould, the size of a glass microscope slide. (C–
D): Each row consists of four traps and a single deflector channel. (E–F): The drawing shows a single 
trap connected to a small suction channel.  
 
Figure 6.3. The 3D photorealistic rendering of mould and PDMS chip-based microfluidic device. A 
high-resolution (125 µm) printed mould was fabricated from optical-grade polymer materials. The 
peeled-off PDMS structure was thermally bonded to a glass slide with inlet and outlet connection 
ports (Ø = 3.0 mm) for PTFE tubing of internal diameter ID= 1.3 mm. 
6.3 Hydrodynamic trapping of dechorionated embryos  
6.3.1 Computer fluid simulation  
The proof-of-concept design of the microfluidic device enabled the passive hydrodynamic 
trapping of a single dechorionated embryo. Computational Fluidics Dynamics (CFD) 
simulations were initially performed (COMSOL Multiphysics v4.4) to predict flow velocity, 
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pressure drop and uniformity of mass transfer inside the microfluidic device. The simulation 
of velocity profile presented in Figure 6.4 indicates that at a perfusion rate of 1000 µl/min, 
velocities inside the chip varied from 0.005 m/s to 0.013 m/s, at input and output 
respectively. There was a constant velocity of 0.011m/s in all the traps. A fluid velocity of 
0.033 m/s in the suction channels immobilised the dechorionated zebrafish embryos for up 
to 72 hours. 
 
Figure 6.4 A computer fluid dynamic simulation of 3D velocity streamlines (m/s) across the 
microfluidic device. Overall perfusion was simulated at the perfusion rate of 1000 µL/min. The flow 
passes from the entrance of each trap through the suction channels and exit through the outlet 
channel. Inset image denotes vertical cross section at the entrance of the trap. This allows for 
embryo immobilisation and efficiency of medium and drug exchange. Note that the axis is the 
coordinate location on the simulation gridlines.  
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The flow velocity was highest across first trap of each row. This was due to the increased 
flow from the designed deflectors (D1–D4) at each of the rows, designed to increase the 
trapping efficiency and push the embryos into the traps; the velocity of moving embryos 
was (>> 1.5–2.0) higher than the turning channels of the main loading channel (Figure 6.5). 
 
Figure 6.5 Analysis of the flow velocity (m/s) when the microfluidic device is perfused at 1000 
µL/min. 3D computer simulation of the flow velocity across each of the traps. A higher velocity at the 
first trap in each row enhanced trapping efficiency. This is a function of the serpentine design of the 
device.  
A uniform and efficient delivery of drugs into immobilised embryos is important for long-
term microperfusion studies in ecotoxicology and for drug discovery. The design of each 
trap permitted the toxicants/drugs to flow around the embryos. Computation of mass flow 
resulted in the distribution of the drugs inside the microfluidic device at a given perfusion 
rate. These mass transfer simulations were validated experimentally using a 0.04% Trypan 
blue dye (Life Technologies Corp, CA, USA) to visually demonstrate the flow of fluid inside 
the entire microfluidic chip (Figure 6.6).  
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Figure 6.6 Computer fluid simulation and validation of mass transfer in the microfluidic chip. The 
chip was perfused with 0.04% of Trypan blue solution at volumetric flow rate of 1000 µl/min. The 
fluid flow images were taken at 0, 10 and 60 seconds of perfusion. The traps achieved 98% of full 
medium exchange with the Trypan blue solution after 60 seconds. Note the flow pattern match 
between simulation and experiment.  
6.3.2 Trapping concept  
The zebrafish embryos were mechanically dechorionated, giving higher survival rates of ≥90% 
than the enzyme-supported treatment using Pronase [256]. Conceptually, the 24 hpf 
dechorionated zebrafish embryos were introduced into the device by drag force from the 
fluid pressure inside the microchannel (Figure 6.7 A–B). The design enabled the trapping and 
immobilisation of an individual embryo using hydrodynamic forces. The embryos trapped in 
the microchannels reduced the flow towards the trap, increased the mainstream flow to 
empty channels. The next embryo in line passed by the occupied trapping channel and went 
in the next empty trap (Figure 6.7 C–D). After all the embryos were trapped, they remained 
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immobilised under a perfusion rate of 1000 µl/min throughout the system. The trapping of 
living dechorionated embryos is demonstrated experimentally in Figure 6.8. It is observed 
that embryo trapping did not occur in sequence because of the nature of the moving 
embryos, twitching while entering the trap. However, the low flow pressure inside occupied 
traps enabled other embryos to enter empty traps until all were fully loaded. 
 
Figure 6.7 Embryo trapping and immobilisation principles. (A) Dechorionated embryos loaded from 
reservoir and directed into the main channel. The hydrodynamic flow guided the embryo to enter 
the trap. (B) The next embryo is moved into the next available trap. (C) The process is repeated until 
all traps are filled. (D) The hydrodynamic force securely retains and immobilises dechorionated 
embryos inside each trap.  
To validate the trapping performance of the microfluidic device, a computer-controlled 
stepper motor-driven peristaltic pump is connected to it. Introduced dechorionated 
embryos rolled freely along the main loading channel towards the available traps. This 
process was repeated until all traps were occupied by an embryo (Figure 6.8). Trapping 
efficiency was also investigated to determine the optimum fluid flow to achieve the 
maximum possible number of trapped embryos. Flow rates from 1500 to 2500 µl/min were 
tested, and it was found that a flow lower than 1000 µl/min, provided insufficient 
hydrodynamic force to move the embryos through the channels due to their mass 
(sedimentation (gravitational force) >> hydrodynamic force). If the fluid flow was too high, 
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the embryos missed the traps and were flushed towards the exit channel, so that the 
numbers of trapped embryos decreased as the flow inside the microfluidic channels rose 
(Figure 6.9). At a flow rate of 1500 uL/min, more than 98% of introduced embryos were 
trapped in the microchannels. Finally, an optimal flow rate of 1500 µl/min achieved 100% 
efficiency, calculated by using this formula: 
                       
                          
                                  
      
 
Figure 6.8 Trapping experiments with 24 hpf dechorionated embryos. The full loading of the 
embryos docking inside the microfluidic chip took approximately ten minutes, depending on the flow 
rate and aspiration flow gap between embryos.  
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Figure 6.9 Embryo trapping efficiency at different perfusion rates. Full loaded embryos with 100% 
trapping efficiency can be achieved at flow rates of 1500 µL/min. High flow rates reduced the 
trapping efficiency due to the inability of the suction channels to overcome the velocity and 
momentum of the embryos moving past.  
Water pressure and shear stress exerted on the embryos are difficult to measure in an on-
chip microenvironment, so experiments were conducted to perform a long-term culture of 
the embryos in microperfusion condition from 24 until 96 hpf. All the trapped embryos went 
through the usual developmental stages during perfusion, including tail detachment (24 
hpf), pigmentation (48 hpf), protruding mouth (72 hpf) and development of the swim 
bladder (96 hpf) (Figure 6.10).  
 
Figure 6.10 Time lapse images of the development of zebrafish embryos during the experiment. 
Embryos were loaded at 1500 µL/min of flow rate, followed by a constant perfusion rate of 1000 
µL/min for on-chip culture for up to 72 hours. The embryos were in dark condition for the duration 
of experiment. 
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Uniform development was observed across all the immobilised embryos. In addition, a 
survival test conducted at 24, 48 and 72 hours returned results comparable with those from 
a the static environment (Figure 6.11). Most of the trapped embryos survived in the 
continuous perfusion flow rate of 1000 µl/min applied inside the microfluidic chip. 
 
Figure 6.11 Survival rates of zebrafish embryos in a perfused flow rate of 1000 µL/min for 72 hours 
period. Embryo viability in microperfusion environments was similar to those in static condition 
using Petri dishes.  
The design of the microfluidic chip with one embryo for one trap is intended to address 
problems associated with the standard protocols using Petri dishes. Its advantages are that 
it significantly simplifies drug/toxicant treatment without displacing the embryos. The 
microfluidic environment, such as the fluid flow, is controllable under continuous perfusion. 
The embryos are isolated and avoid embryo-to-embryo interaction. In addition, image 
acquisition is improved. enhancing data analysis. None of these features can be replicated in 
the standard protocol. 
The capability of performing environmental toxicology without having to displace each 
embryo is important as it increases output performance. Although static protocol using 
conventional Petri dishes is the cheapest way to assess toxicity, it is insufficient for testing 
more toxicant compounds. This is due to the high compound adsorption, lack of supplied 
oxygen, uncontrollable changes in medium and degradation of the test compound. These 
conditions limit the efficiency of the static exposure of the standard fish embryo toxicity test 
(FET) [218]. Lammer et al. have suggested that the dynamic acute in a flow-through system 
should be the preferred option for environmental toxicity analysis. With continuous 
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perfusion of the toxicants, chemical analysis of the medium can be carried out because of 
the known volume used for the test compared with standard FET analysis. This improves the 
quality assurance and the reliability of the data for a comprehensive interpretation of 
toxicity analysis. 
6.4 Continuous microperfusion toxicity assays using dechorionated embryos  
The application of this microfluidic embryo array is for drug toxicity screening. The proof-of-
concept system was investigated by conducting FET based on the standard protocol (OECD 
TG 236). The objective of this experiment was to determine if the FET and Sublethal Embryo 
Toxicity Index (iFET) carried out on the microfluidic chip-based device was equal to or better 
than results from the standard toxicity test using static multiwall plates. Overall outcomes 
from microfluidic device performance were expected to overcome the limitations of the 
standard tests.  
To validate and compare the performance of each method, a median lethal dose 
concentration (LC50) for FET and half maximal response (EC50) for iFET were calculated using 
the scoring criteria stated in the protocols. Several commonly used reference toxicants were 
selected to determine the effectiveness of the microfluidic device with a range of chemical 
compounds. 
6.4.1 Toxicity analysis using FET protocols  
The standard FET test (OECD TG236) protocol was first used to test the toxicity of the 
selected compounds. This protocol lists four lethal endpoints, such as coagulation of the 
embryo, lack of somite formation, non-detachment of tail, and lack of heartbeat (Figure 
6.12). The endpoints were scored every 24 hours up to 72 hours. One of the heavy metal 
compounds, copper sulphate pentahydrate (CuSO4H2O), was selected as the reference 
toxicant for the tests because it is one of the toxic chemicals found in the environment. 
Copper is mostly found in the aquatic environment and has been identified as one of the 
most significant pollutants in water [278]. This substance is found to be toxic at low to high 
concentrations, leading to mortality of the  zebrafish embryos.  
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Figure 6.12 Lethal endpoints (mortality) of zebrafish embryo test at 48 hpf compared with a viable 
embryo (control). Mortality endpoints of coagulation are depicted. Note the lack of somite 
formation and non-detachment of tail were not applicable for embryos at 48 hpf. Lack of heartbeat 
is not illustrated here as it requires video demonstration. 
6.4.2 Chorion as a barrier to toxicant absorption. 
The envelope surrounding the embryos, the chorion, was found to be a barrier to the 
toxicant, and FET protocols were tested both with and without the chorion present. The 
results show that a LC50 value of 0.237 mg/L can be obtained at lower concentrations for 
dechorionated embryos (Figure 6.13). The corresponding values of LC50 for zebrafish 
embryos with the chorion were found to be 0.258 mg/L. This shows that the existence of a 
chorion surrounding an embryo may lead to less sensitivity to the toxicants in drug toxicity 
tests. 
 
Figure 6.13 The effects of copper sulphate on zebrafish embryos with and without chorions after 72 
hours of exposure. The biotests were performed in conventional static culture in 24-well plates. All 
embryos were loaded at 24 hpf. 
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The mortality results show that copper sulphate is toxic at lower concentrations without 
chorions. The value of LC50 using FET protocols was found at a lower concentration of 0.217 
mg/L using microperfusion in a microfluidic environment, compared with the conventional 
static culture (Figure 6.14 A). A strong correlation was found for the relationship between 
both conditions, with a regression value of R2 = 0.9912 showing that the microfluidic 
condition is reliable and can be used with the same protocols (Figure 6.14 B). 
 
 
Figure 6.14 Comparison between biotest performed in microfluidic environments and conventional 
24 well-plates culture. (A) Mortality (FET) was observed for copper sulphate at concentrations of 0.1 
mg/L to 0.5 mg/L. Duration of the test was 72 hours. (B) Cumulative correlation analysis of copper 
sulphate. Excellent agreement between both microfluidic environment and static conditions, as 
depicted by Pearson linear correlation analysis (P<0.01). Error bars represent values between SE 
values performed by three independent experiments.  
6.4.3 Sublethal Fish Embryo Toxicity Index (iFET)  
A new calculation by Wigh et al. was used to calculate the iFET index [258]. This system was 
applied to further the conventional mortality-based FET toxicity test by including sublethal 
and teratogenicity factors. In order to validate and compare the performance of the 
methods, median lethal dose concentrations (LC50) for iFET were calculated using the 
scoring criteria stated in the protocols in Chapter 3 (3.5.2). The scores were based on 
observable sublethal endpoints during imaging acquisition analysis (Figure 6.15). Commonly 
used reference toxicants, caffeine, phenol and nicotine, were selected to determine the 
applicability of the microfluidic device on the range of chemical compounds.  
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Figure 6.15 The sublethal (iFET) endpoints of the zebrafish embryo toxicity test at 48 hpf, compared 
with the viable embryo. iFET endpoints of abnormal eye development, pericardial oedema, lack of 
pigmentation, tail abnormalities, head abnormalities, spine abnormalities and yolk abnormalities are 
illustrated. Note that other two endpoints, heart abnormalities and blood circulation deficiency, are 
not demonstrated here because video capturing is required.  
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Figure 6.16 Comparison of biotests performed in a microfluidic environment and conventional static 
culture of 24 well-plates. iFET (sublethal/teratogenic effects) indicate the several concentrations of 
(A) caffeine (B) nicotine (C) phenol. Cumulative correlation of analysis of (D) caffeine (E) nicotine (F) 
phenol. The lab-on-chip experiments were performed at perfusion rate of 1000 µl/min. Duration of 
all biotests was 72 hours. The error bars represent SE values between three independent 
experiments.  
The sublethal or teratogenic effects (iFET) were observed when 24 hpf dechorionated 
zebrafish embryos were exposed to caffeine, nicotine and phenol. These toxins lead to 
developmental abnormalities which do not cause death. For caffeine, iFET scores of 238.5 
mg/L and 228.9 mg/L were determined using microperfusion and static conditions 
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respectively (Figure 6.16 A). Linear correlation analysis for both conditions was found to 
have R2 value of 0.97 (Pearson and Lee linear correlation test, P<0.01) (Figure 6.16 D). For 
nicotine exposure with concentrations of 100 to 300 mg/L, iFET scores were 194.7 mg/L and 
176.9 mg/L under conditions of microfluidic chip-based device vs static reference, which 
produced R2 value of 0.89 (Pearson and Lee correlation test, P<0.01) (Figure 6.16 B–E). 
Lastly, exposure to phenol returned iFET scores of 159.9 mg/L and 197.7 mg/L for the 
microfluidic system vs well-plate conditions. For both experimental set-ups, the R2 value 
was 0.94 (Pearson and Lee correlation test, P<0.01) (Figure 6.16 C–F). Of all the compounds 
in the biotests, the iFET EC50 value of nicotine was higher than in the 24 well-plate static 
conditions. This shows that nicotine is less toxic to dechorionated zebrafish embryos, and 
corresponds to the correlation value of <90%. This was due to the characteristics of the 
compound itself, which is light sensitive and prone to oxidation [242]. . 
Agreement between both microperfusion and static conditions was found in all used 
compounds including the FET and iFET protocols. The results demonstrate that a flow-
through microperfusion system can increase the sensitivity commonly found in conventional 
24 well- plates in OECD protocols. This system also provides more advantages compared to 
the static system, such as less absorption from polystyrene materials and constant renewal 
of the chemical compounds throughout the experiment. It also proves that a continuous 
perfusion system will have constant oxygen concentrations, which are important for living 
organisms such as zebrafish embryos.  
The automated trapping and immobilisation of dechorionated embryos simplified the 
manual handling required by conventional toxicity tests using well plates. Using a newly 
designed testing platform such as microfluidic device can overcome the limitations of 
current ecotoxicology technologies. 
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6.5 Discussion and conclusions  
In this project, a chip-based microfluidic device for 24 hpf dechorionated zebrafish embryo 
toxicity assays is developed and presented. It overcomes the laborious work in manual 
handling of specimens by employing hydrodynamic, automatic trapping and immobilisation 
of embryos. The chip also allows dechorionated embryos to be cultured in individual traps, 
which improves the imaging of each one. The biotest can be carried out under a continuous 
flow for up to 72 hours without any disturbance to the development of the embryos.  
6.5.1 Design of the lab-on-chip device  
A microfluidic lab-on-chip device was developed that successfully loaded, trapped and 
immobilised 24 hpf dechorionated embryos. It has the potential to replace conventional 
methods of handling small model organisms. Microfluidic systems are small and compact, 
offering great advantages in terms of space. In designing a microfluidic system for small 
model organisms such as zebrafish embryos, survival rates throughout the perfusion time 
are the main concern, especially for dechorionated embryos: long-term perfusion for up to 
72 hours was performed to verify this was possible. 
6.5.2 Comparison between FET and iFET scores on embryos  
 
Figure 6.17 Comparison between end-point scores for FET (mortality) and iFET (sublethal/ 
teratogenic) after exposure of selected compounds on 24 hpf dechorionated embryos. Duration for 
the test was 72 hours. All tests were conducted with a chip-based device. Note that FET parameters 
were included in iFET calculations. The introduction of nine sublethal parameters increases the 
sensitivity beyond that of the standard fish embryo toxicity test. 
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In a standard fish embryo toxicity test, only FET endpoints are scored to determine the 
mortality rate of the embryos. Some compounds such as caffeine, phenol and nicotine do 
not cause mortality at very early stages of exposure, and is observed to have only a 
teratogenic effect on or to cause severe abnormalities in the embryos. Introducing sublethal 
endpoints to the standard protocol of the embryo test improves the sensitivity of the 
toxicants. 
In the toxicity experiments, the results were scored using both FET endpoints (LC50) and iFET 
endpoints (EC50). EC50 values were 16 to 20% higher than LC50 values for caffeine and 
phenol (Figure 6.17). On the other hand, for unstable compound such as nicotine, the LC50 
values were higher than EC50 values by 32%.  
6.5.3 Limitations  
The design of this microfluidic chip-based device was primarily to trap 24 hpf to 96 hpf by 
following the standard protocol for embryo toxicity testing. Toxicity data above this point 
could not be achieved in this case, and specially designed chambers will need to be 
developed to accommodate embryos up to 120 hpf. Standard FET protocols such as OECD 
236 may not be suitable for embryo studies after 24 hpf, which make them less sensitive at 
later developmental stages than 8 hpf embryo for some compounds. A modified FET test 
needs to be developed to improve the accuracy of results.  
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7  Conclusion and Summary 
The practice of using zebrafish embryos as model organisms for bioassays has increased 
tremendously in biomedical and environmental studies. However, few lab-on-chip 
technologies that are available for handling embryos allow automated trapping and high-
throughput screening in a flow-through environment. The primary objective of this thesis is 
to fill the gap caused by this lack. First it develops a method to distinguish between viable 
(live) and dead embryos. Next, it explores the use of additive manufacturing technologies 
capable of fabricating high aspect ratios to replace the conventional lithography process of 
mould-making. This is followed by designing and developing a millifluidic chip-based device 
for trapping and immobilising zebrafish larvae for use in cardiac analysis. Finally, a lab-on-
chip device for loading, trapping and immobilisation of dechorionated embryos is 
fabricated.  
7.1 Achievement and impact  
In Chapter 4, a method to develop a system able to separate live and dead embryos is 
demonstrated. In comparison with conventional and current embryo sorting technologies, 
this system is simple and compact. A proof-of-concept design for a micromechanical large 
particle in-flow sorter for zebrafish embryos, capable of analysing, sorting and dispensing 
live vs dead zebrafish, is demonstrated. This design provides a new paradigm for 
miniaturised and automated sorting devices capable of handling large particles such as 
embryos and small model organisms. This preliminary work offers a platform for improving 
available sorting mechanisms and equipment.  
Chapter 5  presents a biocompatible chip-based physiometric microfluidic device for 
monitoring the cardiac function of zebrafish larvae. By employing the capabilities of 3D 
printing technologies, the time-consuming process of fabricating a mould are eliminated. 
Stereolithography technologies capable of producing high-aspect ratios with high-grade 
optical transparency of moulds improve the conventional method of fabricating PDMS chip-
based devices using laser cutting. This new device is capable of monitoring heartbeat 
without human intervention, overcoming the limitations of manual work in mounting the 
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larvae on agarose. Moreover, as a non-invasive technique this device can be used to see 
variations in heart rate, which is able to overcome the problmes of manual counting of 
heartbeat.  
Chapter 6 describes the use of lab-on-chip technologies in fabricating microfluidic PDMS 
chip-based devices for dechorionated zebrafish embryo biotests carried out under 
continuous perfusion. This device is capable to perform biotests that are more effectively 
than conventional manual bioassays. 
7.2 Limitations and future work  
A detection method was developed to sort zebrafish embryos., and a sorting concept design 
was fabricated that could directly move sorted embryos into required channels. As a fully 
automation system to integrate detection and sorting still needs to be developed, future 
work will concentrate on developing a fully integrated sorting system combined with 
automated loading, real-time sort decision-making algorithms and automated dispensing of 
embryos for pharmacological testing.  
A proof-of-concept of microfluidic design for cardiotoxicity studies on zebrafish larvae was 
developed here. Heart rates were measured using non-invasive methods; however, it is not 
clear how exactly absorption and elimination rates need to be addressed in order to achieve 
a precise calculation of the amount of drugs associated with the process. The larvae should 
be placed in array where perfusion can be carried out simultaneously with the drugs 
absorption of the drugs. Future works will concentrate on improving the design for 
pharmacological applications, particularly by integrating a monitoring system directly with 
programmable algorithm software to enable automatic counting of the heart beat.  
A microfluidic chip device was fabricated for loading, trapping and immobilising live 
dechorionated embryos. Its design, however, is suitable for trapping embryos only up to 72 
hours. This is because the embryos begin to swim after 96 hpf, and toxicity of the larvae 
beyond this period can not yet be achieved. In future, developmental work should focus on 
microperfusion arrays capable of docking embryos up to 120 hpf or more in specially 
designed chambers.  
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In brief, future research work will improve on the design to increase the throughput or the 
automation for loading and unloading of the zebrafish embryos. In addition, an integration 
approach of the these developed devices will also develop so that it can perform the 
sorting, drug testing and analysis in one Fish-on-Chip system.  
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 Appendices 
A1 Software programming 
Roborealm software 
Specifications  
 
 
Figure 7.1 Graphic user interface of real time image processing software (RoboRealm, Machine 
Vision). (1) Camera connects to the software and the object appear on the image screen. (2) The 
specific function for image processing is selected in the Modules section. Each inserted module 
directly processes the image. (3) Selected modules appeared in the processing pipelines screen as 
algorithms. At completion of all selected modules, the image is displayed. Note the blue circle only 
appears when all the modules in the pipelines are processed.  
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Definition of algorithm terms used in image processing in Chapter 4.0: 
1. RGB filter 
This module identifies and focuses on the colour pixels within an image at a given 
threshold and with specified colours to track. The grey filter was selected based on 
the colour of the current image.  
2. Smooth Hull 
This is used to smooth a blob shape’s border without loss of sharp edges.  
3. Blob tracking 
This module tracks an object identified from others by its pixels. It labels it with a 
specific identifier to differentiate it from other objects.  
4. Blob replace 
The white blob in the current image will be replaced with another specific colour or 
shape that can be selected in the interface. 
5. Canny 
This module is developed as for edge detection, and selects only the edges around 
the current image. 
6. Circles 
This module recognises contours within a circular image. It is normally run after a 
contour-based module such as Canny. The module determines the contours inside a 
circular shape and selects that specific shape for subsequent image processing. 
7. Display circle 
The shape of a circle can be drawn based on a single point and the radius. The circle 
will be displayed on the image screen. 
8. Write AVI 
The processed video can be saved to an AVI video file and can then be played back 
on any AVI player. This module allows playback of the video without running the 
Roborealm software.  
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A2 Technical specifications of instruments 
Microfabrication equipment 
No Instruments Specifications/ 
1. CO2 Laser Cutting System 
(Universal Laser Systems, VLS 
3.50)  
  
  
  
 
 
Size/Dimensions: 
864 mm x 365 mm x 635 mm 
Work Area:  
610 mm x 305 mm 
Optical lenses: 
Standard and High Power Density Focus Optics 
(HDPFO) 
Beam spot size: 
100 µm (Standard 
40 µm (HDPFO) 
Laser power: 30 W 
2 Stereolithography 3D printer 
(ProJet HD 7000, 3D Systems)  
  
  
  
  
 
Size/Dimensions: 
1860 mm x 982 mm x 2070 mm 
Build Volume:  
380 mm x 380 mm x 250 mm 
Layer resolution: 
125 µm 
Accuracy: 
0.025–0.05 mm 
Materials: 
VisiJet SL Clear, VisiJet SL Black, VisiJet SL Flex 
Support Material:  
 
3 MultiJet Machining 
(Objet Connex 350, Stratasys)  
  
  
 
 
Size/Dimensions: 
1400 mm x 1260 mm x 1100 mm 
Build Volume:  
342 mm x 342 mm x 200 mm 
Layer resolution: 
16 µm 
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Accuracy: 
 200 µm  
Materials: 
VeroClear, VeroPureWhite, VeroGray 
Support materials: 
SUP705 (remove by water jet) 
 
4 High Resolution Desktop 3D 
Printer 
(Form1, FormLabs) 
Size/Dimensions: 
300 mm x 280 mm x 450 mm 
Build Volume:  
125 mm x 125 mm x 165 mm 
Layer resolution: 
25–200 µm 
Accuracy: 
 300 µm 
Materials: 
FormClear resin 
Support materials: 
Same as work material 
 
5 Fused Deposition Modelling 
Desktop 3D Printer 
(MakerBot Replicator, Stratsys) 
Size/Dimensions: 
528 mm x 441 mm x 410 mm 
Build Volume:  
295 mm x 195 mm x 165 mm 
Layer resolution: 
100 µm 
Accuracy: 
 100–400 µm  
Materials: 
PLA filament 
Support materials: 
PLA filament 
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6 Peristaltic Pump 
(Miniplus Evolution, Gilson, Inc.) 
Pump head: 
MF (medium flow)  
Flow rate: 
PVC tubing – up to 47 mL/min 
Isoversinic – up to 70 mL/min 
Silicone – up to 31 mL/min  
 
7  Water bath 
(TW2, Julabo Labortechnik GmbH) 
Equipped with microprocessor 
technology with PID temperature 
controller.  
  
  
 
 
Size/Dimensions: 
170 mm x 160 mm x 260 mm 
Bath size:  
150 mm x 130 mm x 110 mm 
Water volume: 1–2 Litre 
Working temperature range: 
 20–99.9 °C 
Temperature stability: ±0.2 °C 
 
 Oxygen Plasma 
(Harrick Plasma,) 
Size/Dimensions: 
216 mm x 254 mm x 203 mm 
Features:  
Desktop unit 
Adjustable RF power settings (Low, medium, 
high) 
Maximum power: 18 W 
Working pressure: 200 mTorr 
 
 Microscope (Leica)  
  
  
  
  
 
 
 
 USB Microscope  
(Dino-Lite, AnMo Electronics 
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Corporation, Taiwan) 
AM-3713 TB 
 
Size/Dimensions: 
1050 mm (length) x 320 mm (diameter) 
Weight: 105 g  
Resolution: VGA (640x480 pixels) 
Optimal magnification:  
10–70x, 200x 
Sensor type: CMOS 
Max frame rate: 60 fps 
 
 AD7013MZT(R4) Size/Dimensions: 
1050 mm (length) x 320 mm (diameter) 
Weight: 140 g  
Resolution: 2592 X 1944 pixels 
Optimal magnification:  
10–50x, 240x 
Sensor type: CMOS 
Max frame rate: 30 fps 
 
 LED Base Illumination Stage 
(BL-ZW1 Dino-Lite backlight pad)  
Size/Dimensions: 
100 mm x 90 mm x 20 mm 
Features:  
Adjustable polarisation 
Operating voltage: 5V 
Light intensity: Over 5000 cd/m2 
 
 3D Optical Microscope 
(BRUKER, Contour GT-I)  
Size/Dimensions: 
452 mm x 534 mm x 683 mm 
Features:  
Automated stitching, scatter and grid 
automation 
Tip/tilt function: ± 5° 
Dual -LED illumination 
Vision64 analysis software (Annular analysis; 
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Optical Analysis; Advanced Image Processing) 
Maximum scan range: Up to 10 mm 
Vertical resolution: < 0.01 mm 
Zoom lenses:  
0.55x, 0.75x, 1x, 1.5x, 2x 
Resolution: 1280 x 960 pixels 
 
 Stereomicroscope 
(Nikon SMZ18, Fluorescence 
Microscope) 
Size/Dimensions: 
337 mm x 300 mm x 492 mm 
Features:  
Built in OCC illumination 
Fibre light source  
Epi fluorescence attachment 
Motorised focus unit 
Parallel optic (zooming type) 
Magnification range: 3.75 – 270x 
Zoom ratio: 18:1 
Resolution: 1280 x 960 pixels 
 
 Microbiological Incubator 
(Thermo Scientific, Heratherm TM 
Size/Dimensions: 
470 mm x 260 mm x 415 mm 
Features:  
Control LED display  
Temperature uniformity (± 1.2 °C) and stability 
(± 0.2 °C). 
High temperature accuracy 
Temperature range: 17°C – 40 °C 
 
 Advanced Protocol Oven 
(Thermo Scientific, Heratherm TM)  
Size/Dimensions: 
343 mm x 354 mm x 508 mm 
Features:  
Programmable microprocessor control with 
vacuum fluorescent display. 
Temperature stability (± 1.8 °C). 
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High speed drying and heating  
Independent data monitoring 
Function control for rapid heating up 
Temperature range: up to 330 °C 
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